<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2025"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2025"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:nuwe="http://nuwellis.com/20251231"
  xmlns:us-gaap="http://fasb.org/us-gaap/2025"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xhtml="http://www.w3.org/1999/xhtml"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="nuwe-20251231.xsd" xlink:type="simple"/>
    <context id="From2025-01-01to2025-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_MrJaramilloMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">nuwe:MrJaramilloMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_MrErbMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">nuwe:MrErbMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_MrJaramilloMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">nuwe:MrJaramilloMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_MrErbMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">nuwe:MrErbMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_MrJaramilloMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">nuwe:MrJaramilloMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_MrErbMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">nuwe:MrErbMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-02-28_custom_MrJaramilloMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">nuwe:MrJaramilloMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-02-28</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_MrJaramilloMember_ecd_PeoMember_custom_ReportedValueOfEquityAwardsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">nuwe:ReportedValueOfEquityAwardsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">nuwe:MrJaramilloMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ecd_PeoMember_ecd_EqtyAwrdsAdjsMember_custom_MrJaramilloMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsAdjsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">nuwe:MrJaramilloMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_custom_MrJaramilloMember_ecd_PeoMember_custom_ReportedValueOfEquityAwardsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">nuwe:ReportedValueOfEquityAwardsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">nuwe:MrJaramilloMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ecd_PeoMember_ecd_EqtyAwrdsAdjsMember_custom_MrJaramilloMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsAdjsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">nuwe:MrJaramilloMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_custom_MrJaramilloMember_ecd_PeoMember_custom_ReportedValueOfEquityAwardsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">nuwe:ReportedValueOfEquityAwardsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">nuwe:MrJaramilloMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ecd_PeoMember_ecd_EqtyAwrdsAdjsMember_custom_MrJaramilloMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsAdjsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">nuwe:MrJaramilloMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_custom_MrErbMember_ecd_PeoMember_custom_ReportedValueOfEquityAwardsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">nuwe:ReportedValueOfEquityAwardsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">nuwe:MrErbMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ecd_PeoMember_ecd_EqtyAwrdsAdjsMember_custom_MrErbMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsAdjsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">nuwe:MrErbMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ecd_PeoMember_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_custom_MrJaramilloMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">nuwe:MrJaramilloMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ecd_PeoMember_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_custom_MrJaramilloMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">nuwe:MrJaramilloMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ecd_PeoMember_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_custom_MrJaramilloMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">nuwe:MrJaramilloMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ecd_PeoMember_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_custom_MrJaramilloMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">nuwe:MrJaramilloMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ecd_PeoMember_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_custom_MrJaramilloMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">nuwe:MrJaramilloMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ecd_PeoMember_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_custom_MrJaramilloMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">nuwe:MrJaramilloMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ecd_PeoMember_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember_custom_MrJaramilloMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">nuwe:MrJaramilloMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ecd_PeoMember_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_custom_MrJaramilloMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">nuwe:MrJaramilloMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ecd_PeoMember_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_custom_MrJaramilloMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">nuwe:MrJaramilloMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ecd_PeoMember_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_custom_MrJaramilloMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">nuwe:MrJaramilloMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ecd_PeoMember_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_custom_MrJaramilloMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">nuwe:MrJaramilloMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ecd_PeoMember_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_custom_MrJaramilloMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">nuwe:MrJaramilloMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ecd_PeoMember_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_custom_MrJaramilloMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">nuwe:MrJaramilloMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ecd_PeoMember_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember_custom_MrJaramilloMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">nuwe:MrJaramilloMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ecd_PeoMember_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_custom_MrJaramilloMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">nuwe:MrJaramilloMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ecd_PeoMember_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_custom_MrJaramilloMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">nuwe:MrJaramilloMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ecd_PeoMember_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_custom_MrJaramilloMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">nuwe:MrJaramilloMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ecd_PeoMember_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_custom_MrJaramilloMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">nuwe:MrJaramilloMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ecd_PeoMember_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_custom_MrJaramilloMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">nuwe:MrJaramilloMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ecd_PeoMember_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_custom_MrJaramilloMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">nuwe:MrJaramilloMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ecd_PeoMember_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember_custom_MrJaramilloMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">nuwe:MrJaramilloMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ecd_PeoMember_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_custom_MrErbMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">nuwe:MrErbMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ecd_PeoMember_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_custom_MrErbMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">nuwe:MrErbMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ecd_PeoMember_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_custom_MrErbMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">nuwe:MrErbMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ecd_PeoMember_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_custom_MrErbMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">nuwe:MrErbMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ecd_PeoMember_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_custom_MrErbMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">nuwe:MrErbMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ecd_PeoMember_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_custom_MrErbMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">nuwe:MrErbMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ecd_PeoMember_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember_custom_MrErbMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:IndividualAxis">nuwe:MrErbMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ecd_NonPeoNeoMember_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ecd_NonPeoNeoMember_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ecd_NonPeoNeoMember_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ecd_NonPeoNeoMember_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ecd_NonPeoNeoMember_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ecd_NonPeoNeoMember_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ecd_NonPeoNeoMember_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ecd_NonPeoNeoMember_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ecd_NonPeoNeoMember_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ecd_NonPeoNeoMember_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ecd_NonPeoNeoMember_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2025-01-012025-12-31_ecd_NonPeoNeoMember_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2025-01-01</startDate>
            <endDate>2025-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ecd_NonPeoNeoMember_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ecd_NonPeoNeoMember_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ecd_NonPeoNeoMember_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ecd_NonPeoNeoMember_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ecd_NonPeoNeoMember_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2024-01-012024-12-31_ecd_NonPeoNeoMember_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ecd_NonPeoNeoMember_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ecd_NonPeoNeoMember_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ecd_NonPeoNeoMember_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ecd_NonPeoNeoMember_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ecd_NonPeoNeoMember_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="From2023-01-012023-12-31_ecd_NonPeoNeoMember_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001506492</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <dei:AmendmentFlag contextRef="From2025-01-01to2025-12-31" id="Fact000003">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey contextRef="From2025-01-01to2025-12-31" id="Fact000004">0001506492</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="From2025-01-01to2025-12-31" id="xdx2ixbrl0010">DEF 14A</dei:DocumentType>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="From2025-01-01to2025-12-31"
      decimals="0"
      id="xdx2ixbrl0136"
      unitRef="USD">306100</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="From2025-01-01to2025-12-31"
      decimals="0"
      id="xdx2ixbrl0139"
      unitRef="USD">306100</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="xdx2ixbrl0144"
      unitRef="USD">446458</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="xdx2ixbrl0147"
      unitRef="USD">351185</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <dei:EntityRegistrantName contextRef="From2025-01-01to2025-12-31" id="Fact000011">NUWELLIS, INC.</dei:EntityRegistrantName>
    <ecd:InsiderTrdPoliciesProcAdoptedFlag contextRef="From2025-01-01to2025-12-31" id="Fact000013">true</ecd:InsiderTrdPoliciesProcAdoptedFlag>
    <ecd:AwardTmgMnpiDiscTextBlock contextRef="From2025-01-01to2025-12-31" id="Fact000015">&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;i&gt;&lt;span id="a019"&gt;&lt;/span&gt;Equity
Compensation.&#x2009;&lt;/i&gt;&lt;/b&gt;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIEF3YXJkIFRpbWluZyBEaXNjbG9zdXJlAA__" id="xdx_905_eecd--AwardTmgMethodTextBlock_c20250101__20251231_zTOq7BIBlwP9" title="Award Timing Method"&gt;The Compensation Committee is responsible for granting equity-based incentive awards to our executive
officers.&lt;/span&gt; The Compensation Committee does not grant equity awards to our executive officers on a predetermined schedule. &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIEF3YXJkIFRpbWluZyBEaXNjbG9zdXJlAA__" id="xdx_909_eecd--AwardTmgHowMnpiCnsdrdTextBlock_c20250101__20251231_zZX14E6OsQ07" title="Award Timing, How MNPI Considered"&gt;The Compensation
Committee has not established policies and practices regarding timing of equity awards in relation to the release of &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIEF3YXJkIFRpbWluZyBEaXNjbG9zdXJlAA__" id="xdx_90F_eecd--AwardTmgMnpiCnsdrdFlag_dbF_c20250101__20251231_zPBIfc3fz4o7" title="Award Timing MNPI Considered"&gt;material
nonpublic information&lt;/span&gt; and does not time the public release of such information based on equity award grant dates nor for the purpose
of affecting the value of executive compensation.&lt;/span&gt; The Compensation Committee does not consider material nonpublic information
in setting terms of equity awards, such as grant size or vesting conditions. Vesting of equity awards is generally tied to continuous
service with us and serves as an additional retention measure.&#x2009;&lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIEF3YXJkIFRpbWluZyBEaXNjbG9zdXJlAA__" id="xdx_904_eecd--MnpiDiscTimedForCompValFlag_dbF_c20250101__20251231_zDKgwHRFXlt7" title="MNPI Disclosure Timed for Compensation Value"&gt;No&lt;/span&gt; equity-based incentive awards were granted to the executive
officers in 2025, except the option grant to John Erb concurrent with his appointment as President and Chief Executive Officer
of the Company.&lt;/span&gt;</ecd:AwardTmgMnpiDiscTextBlock>
    <ecd:AwardTmgMethodTextBlock contextRef="From2025-01-01to2025-12-31" id="Fact000017">The Compensation Committee is responsible for granting equity-based incentive awards to our executive
officers.</ecd:AwardTmgMethodTextBlock>
    <ecd:AwardTmgHowMnpiCnsdrdTextBlock contextRef="From2025-01-01to2025-12-31" id="Fact000019">The Compensation
Committee has not established policies and practices regarding timing of equity awards in relation to the release of &lt;span class="xdx_phnt_RGlzY2xvc3VyZSAtIEF3YXJkIFRpbWluZyBEaXNjbG9zdXJlAA__" id="xdx_90F_eecd--AwardTmgMnpiCnsdrdFlag_dbF_c20250101__20251231_zPBIfc3fz4o7" title="Award Timing MNPI Considered"&gt;material
nonpublic information&lt;/span&gt; and does not time the public release of such information based on equity award grant dates nor for the purpose
of affecting the value of executive compensation.</ecd:AwardTmgHowMnpiCnsdrdTextBlock>
    <ecd:AwardTmgMnpiCnsdrdFlag contextRef="From2025-01-01to2025-12-31" id="Fact000021">false</ecd:AwardTmgMnpiCnsdrdFlag>
    <ecd:MnpiDiscTimedForCompValFlag contextRef="From2025-01-01to2025-12-31" id="Fact000023">false</ecd:MnpiDiscTimedForCompValFlag>
    <ecd:PvpTableTextBlock contextRef="From2025-01-01to2025-12-31" id="Fact000025">&lt;p id="xdx_806_eecd--PvpTableTextBlock_dU_zKuOco8iTr51" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&lt;b&gt;&lt;span style="text-decoration: underline"&gt;2025
Pay Versus Performance Table&lt;/span&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_302_z7TOPvdOIiZ9" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto" summary="xdx: Disclosure - Pay vs Performance Disclosure"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"&gt;&lt;b&gt;Year&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"&gt;&lt;b&gt;Summary
                                         compensation table total for PEO ($) (Mr. Jaramillo) (1)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"&gt;&lt;b&gt;Compensation
                                         actually paid to PEO ($) (Mr. Jaramillo) (2)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;Summary
    compensation table total for PEO ($) (Mr. Erb) (1)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"&gt;&lt;b&gt;Compensation
                                         actually paid to PEO ($) &lt;br/&gt;
(Mr. Erb) (2)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 5%; text-align: center"&gt;2025&lt;/td&gt;&lt;td style="width: 1%; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eecd--PeoTotalCompAmt_pp0p0_c20250101__20251231__ecd--IndividualAxis__custom--MrJaramilloMember_fKDEp_z8FCg5WpQqLb" style="width: 12%; text-align: center" title="PEO Total Compensation Amount"&gt;324,328&lt;/td&gt;&lt;td style="width: 1%; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eecd--PeoActuallyPaidCompAmt_pp0p0_c20250101__20251231__ecd--IndividualAxis__custom--MrJaramilloMember_fKDIp_zvT2TMH8X3Bl" style="width: 10%; text-align: center" title="PEO Actually Paid Compensation Amount"&gt;324,328&lt;/td&gt;&lt;td style="width: 1%; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eecd--PeoTotalCompAmt_pp0p0_c20250101__20251231__ecd--IndividualAxis__custom--MrErbMember_fKDEp_zHG2y0DcgHag" style="width: 10%; text-align: center" title="PEO Total Compensation Amount"&gt;336,180&lt;/td&gt;&lt;td style="width: 1%; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eecd--PeoActuallyPaidCompAmt_pp0p0_c20250101__20251231__ecd--IndividualAxis__custom--MrErbMember_fKDIp_zmL4G0k84jIi" style="width: 10%; text-align: center" title="PEO Actually Paid Compensation Amount"&gt;313,320&lt;/td&gt;&lt;td style="width: 1%; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: center"&gt;2024&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eecd--PeoTotalCompAmt_pp0p0_c20240101__20241231__ecd--IndividualAxis__custom--MrJaramilloMember_fKDEp_zpYhXqA9cQS7" style="text-align: center" title="PEO Total Compensation Amount"&gt;409,408&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eecd--PeoActuallyPaidCompAmt_pp0p0_c20240101__20241231__ecd--IndividualAxis__custom--MrJaramilloMember_fKDIp_zXrCqmbuqD3h" style="text-align: center" title="PEO Actually Paid Compensation Amount"&gt;387,861&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eecd--PeoTotalCompAmt_pp0p0_d0_c20240101__20241231__ecd--IndividualAxis__custom--MrErbMember_fKDEp_zp84kv4CHWqj" style="font-weight: bold; text-align: center" title="PEO Total Compensation Amount"&gt;-&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eecd--PeoActuallyPaidCompAmt_pp0p0_d0_c20240101__20241231__ecd--IndividualAxis__custom--MrErbMember_fKDIp_z52HWbu8mYsf" style="font-weight: bold; text-align: center" title="PEO Actually Paid Compensation Amount"&gt;-&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: center"&gt;2023&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eecd--PeoTotalCompAmt_pp0p0_c20230101__20231231__ecd--IndividualAxis__custom--MrJaramilloMember_fKDEp_zOfcIMROGY1i" style="text-align: center" title="PEO Total Compensation Amount"&gt;606,603&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eecd--PeoActuallyPaidCompAmt_pp0p0_c20230101__20231231__ecd--IndividualAxis__custom--MrJaramilloMember_fKDIp_zX70B7dcSWcf" style="text-align: center" title="PEO Actually Paid Compensation Amount"&gt;423,659&lt;/td&gt;&lt;td style="text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eecd--PeoTotalCompAmt_pp0p0_d0_c20230101__20231231__ecd--IndividualAxis__custom--MrErbMember_fKDEp_zGbZf27cEjo2" style="font-weight: bold; text-align: center" title="PEO Total Compensation Amount"&gt;-&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eecd--PeoActuallyPaidCompAmt_pp0p0_d0_c20230101__20231231__ecd--IndividualAxis__custom--MrErbMember_fKDIp_ziUb9ChyrvBe" style="font-weight: bold; text-align: center" title="PEO Actually Paid Compensation Amount"&gt;-&lt;/td&gt;&lt;td style="font-weight: bold; text-align: center"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"&gt;&lt;b&gt;Year&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"&gt;&lt;b&gt;Average
                                         summary compensation table total for non-PEO named executive officers ($)&lt;sup&gt;(3)&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"&gt;&lt;b&gt;Average
                                         compensation actually paid to non-PEO named executive officers ($)&lt;sup&gt;(4)&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt; &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"&gt;&lt;b&gt;Value
                                         of initial fixed $100 investment based on Total shareholder return ($)&lt;sup&gt;(5)&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"&gt;&lt;b&gt;Net
                                         loss ($)&lt;sup&gt;(6)&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 5%; text-align: right"&gt;2025&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eecd--NonPeoNeoAvgTotalCompAmt_pp0p0_c20250101__20251231_fKDMp_ztA5kKVeW5Zj" style="width: 12%; text-align: right" title="Non-PEO NEO Average Total Compensation Amount"&gt;306,100&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eecd--NonPeoNeoAvgCompActuallyPaidAmt_pp0p0_c20250101__20251231_fKDQp_zdqlJSnatnZ9" style="width: 10%; text-align: right" title="Non-PEO NEO Average Compensation Actually Paid Amount"&gt;306,100&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_986_eecd--TotalShareholderRtnAmt_pp2d_c20250101__20251231_fKDUp_zo0HJ2K3PXde" style="width: 10%; text-align: right" title="Total Shareholder Return Amount"&gt;0.17&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eus-gaap--NetIncomeLoss_uUSD_c20250101__20251231_fKDYp_zXImRVTcBJi4" style="width: 10%; text-align: right" title="Net Income (Loss)"&gt;17,521,000&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: right"&gt;2024&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eecd--NonPeoNeoAvgTotalCompAmt_pp0p0_c20240101__20241231_fKDMp_z2WwIaYIJu8e" style="text-align: right" title="Non-PEO NEO Average Total Compensation Amount"&gt;288,472&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eecd--NonPeoNeoAvgCompActuallyPaidAmt_pp0p0_c20240101__20241231_fKDQp_ztxM4ENnd5E8" style="text-align: right" title="Non-PEO NEO Average Compensation Actually Paid Amount"&gt;271,930&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_989_eecd--TotalShareholderRtnAmt_pp2d_c20240101__20241231_fKDUp_zrTLJ2Y8O0K2" style="text-align: right" title="Total Shareholder Return Amount"&gt;0.03&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eus-gaap--NetIncomeLoss_uUSD_c20240101__20241231_fKDYp_zSFgzZsd3u8" style="text-align: right" title="Net Income (Loss)"&gt;11,165,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: right"&gt;2023&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eecd--NonPeoNeoAvgTotalCompAmt_pp0p0_c20230101__20231231_fKDMp_zdp51cnTeaOi" style="text-align: right" title="Non-PEO NEO Average Total Compensation Amount"&gt;446,458&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eecd--NonPeoNeoAvgCompActuallyPaidAmt_pp0p0_c20230101__20231231_fKDQp_zEmMpAVrfRC9" style="text-align: right" title="Non-PEO NEO Average Compensation Actually Paid Amount"&gt;351,185&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;$&lt;/td&gt;&lt;td id="xdx_984_eecd--TotalShareholderRtnAmt_pp2d_c20230101__20231231_fKDUp_zS74yzToTDb1" style="text-align: right" title="Total Shareholder Return Amount"&gt;0.47&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eus-gaap--NetIncomeLoss_uUSD_c20230101__20231231_fKDYp_zyagINZ6Ls91" style="text-align: right" title="Net Income (Loss)"&gt;20,209,000&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p id="xdx_84D_eecd--NamedExecutiveOfficersFnTextBlock_dU_zhrvPZU1UD97" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 4%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"&gt;&lt;sup id="xdx_F0E_zWYc8phxWyq"&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 96%"&gt;&lt;span id="xdx_F1B_zIEL5hdMfia3" style="font-family: Times New Roman, Times, Serif; font-size: 8pt"&gt;Reflects
    the amount reported in the &#x201c;Total&#x201d; column of the Summary Compensation Table for each of &lt;span id="xdx_90B_eecd--PeoName_c20250101__20251231__ecd--IndividualAxis__custom--MrErbMember_zf1sFgyp6Dua"&gt;Mr. Erb&lt;/span&gt; and &lt;span id="xdx_904_eecd--PeoName_c20230101__20231231__ecd--IndividualAxis__custom--MrJaramilloMember_zPUdSol0ZkZ5"&gt;&lt;span id="xdx_901_eecd--PeoName_c20240101__20241231__ecd--IndividualAxis__custom--MrJaramilloMember_zUxUINMYfZj3"&gt;&lt;span id="xdx_904_eecd--PeoName_c20250101__20250228__ecd--IndividualAxis__custom--MrJaramilloMember_zpuUh1Zryfi3"&gt;Mr. Jaramillo&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;
    for each corresponding year in which they served as PEO. Mr. Jaramillo was our PEO from 2023 to February 2025, and Mr. Erb
    was our PEO from February 2025 to December 2025. The amount reported in the &#x201c;Total&#x201d; column of the Summary Compensation
    Table for Mr. Jaramillo includes $224,561.19 of Separation Pay in 2025. The amount reported in the &#x201c;Total&#x201d; column
    of the Summary Compensation Table for Mr. Erb includes $49,300 and $8,036 of compensation for service as Chairman of the Board
    in 2024 and 2025, respectively. See &#x201c;Named Executive Officer Compensation Tables - Summary Compensation Table for 2025
    and 2024&#x201d; and &#x201c;Named Executive Officer Compensation Tables - Summary Compensation Table for 2024 and 2023&#x201d;
    in our 2025 Definitive Proxy Statement filed with the SEC on April 14, 2025.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="display: none; vertical-align: top; text-align: left; visibility: hidden"&gt;
  &lt;td style="display: none; width: 3%; visibility: hidden"&gt;&lt;sup id="xdx_F0B_zBGw0qcxpo76"&gt;(2)&lt;/sup&gt;&lt;/td&gt;
  &lt;td id="xdx_F17_zcVeNnZdl3C8" style="display: none; width: 97%; visibility: hidden"&gt;The amounts reported in this column represent CAP for Mr. Erb and Mr. Jaramillo for each corresponding year in which they served as PEO
computed as required by Item 402(v) of Regulation S-K. The reported amounts do not reflect the actual compensation earned by or paid to
Mr. Erb or Mr. Jaramillo during any applicable year. To determine CAP, the adjustments below were made to Mr. Erb&#x2019;s and Mr. Jaramillo&#x2019;s
total compensation.&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="display: none; vertical-align: top; text-align: left; visibility: hidden"&gt;
  &lt;td style="display: none; visibility: hidden"&gt;&lt;sup id="xdx_F01_zJcZsZXnDS24"&gt;(3)&lt;/sup&gt;&lt;/td&gt;
  &lt;td id="xdx_F1D_zDid4KryHas6" style="display: none; visibility: hidden"&gt;Reflects the average amount reported in the &#x201c;Total&#x201d; column of the Summary Compensation Table for our other NEOs as a group
(excluding Mr. Erb and Mr. Jaramillo) for each corresponding year. See &#x201c;Named Executive Officer Compensation Tables - Summary Compensation
Table for 2025 and 2024&#x201d; and &#x201c;Named Executive Officer Compensation Tables - Summary Compensation Table for 2024 and 2023&#x201d;
in our 2025 Definitive Proxy Statement filed with the SEC on April 14, 2025. The names of each of the other NEOs (excluding Mr. Erb and
Mr. Jaramillo) Included for purposes of calculating the average amounts in each applicable year are Mr. Ayotte, Ms. Blake, and Mr. Scott
for 2023, Mr. Ayotte and Mr. Scott for 2024, and Mr. Ayotte and Mr. Scott for 2025. Since Ms. Blake and Mr. Scott served as Chief Financial
Officer for a portion of 2023 and Mr. Scott served as Chief Financial Officer for a portion of 2025, the compensation of each such non-PEO
NEO has been included for purposes of calculating the average summary compensation table total in each respective year. In addition to
serving as our PEO, Mr. Erb served as Interim Chief Financial Officer for a portion of 2025 and did not receive any additional compensation
for serving in this role during the applicable year. Mr. Erb&#x2019;s compensation for 2025 has not been included for purposes of calculating
the average summary compensation total in that year.&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="display: none; vertical-align: top; text-align: left; visibility: hidden"&gt;
  &lt;td style="display: none; visibility: hidden"&gt;&lt;sup id="xdx_F09_zijKcgYdRyxk"&gt;(4)&lt;/sup&gt;&lt;/td&gt;
  &lt;td id="xdx_F1F_zCcdskAICmfe" style="display: none; visibility: hidden"&gt;Amounts reported reflect CAP for the other NEOs as a group (excluding Mr. Erb and Mr. Jaramillo), as computed in accordance with Item
402(v) of Regulation S- K, for each corresponding year, which amounts reflect an average of the actual amount of compensation earned by
or paid to the other NEOs as a group (excluding Mr. Erb and Mr. Jaramillo) during the applicable year. The adjustments below were made
to the average total compensation for the NEOs as a group (excluding Mr. Erb and Mr. Jaramillo) for each year to determine the CAP for
such year. Since both Ms. Blake and Mr. Scott served as Chief Financial Officer for a portion of 2023, and Mr. Scott served as Chief Financial
Officer for a portion of 2025, these two non-PEO NEOs have been treated as one full-time equivalent individual for purposes of calculating
the average compensation actually paid to non-PEO NEOs in each respective year. In addition to serving as our PEO, Mr. Erb served as Interim
Chief Financial Officer for a portion of 2025 and did not receive any additional compensation for serving in this role during the applicable
year.&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="display: none; vertical-align: top; text-align: left; visibility: hidden"&gt;
  &lt;td style="display: none; visibility: hidden"&gt;&lt;sup id="xdx_F01_z3SyGnIFlie8"&gt;(5)&lt;/sup&gt;&lt;/td&gt;
  &lt;td id="xdx_F19_z9OAM0UIGHx9" style="display: none; visibility: hidden"&gt;The amounts reported in this column represent the Company&#x2019;s cumulative TSR, which is calculated by dividing the sum of the cumulative
amount of dividends for the measurement period, assuming dividend reinvestment, and the difference between the Company&#x2019;s share price
at the end of the measurement period and the beginning of the measurement period by the Company&#x2019;s share price at the beginning of
the measurement period.&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="display: none; vertical-align: top; text-align: left; visibility: hidden"&gt;
  &lt;td style="display: none; visibility: hidden"&gt;&lt;sup id="xdx_F01_zYEjJKfWFnLh"&gt;(6)&lt;/sup&gt;&lt;/td&gt;
  &lt;td id="xdx_F1F_z4E7oRTnEPi5" style="display: none; visibility: hidden"&gt;The amounts reported in this column represent net income reflected in the Company&#x2019;s audited financial statements for the applicable
year.&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_852_zT789uxov4w7" style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;


&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 4%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"&gt;&lt;sup&gt;(2)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 96%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"&gt;The
    amounts reported in this column represent CAP for Mr. Erb and Mr. Jaramillo for each corresponding year in which they served
    as PEO computed as required by Item 402(v) of Regulation S-K. The reported amounts do not reflect the actual compensation
    earned by or paid to Mr. Erb or Mr. Jaramillo during any applicable year. To determine CAP, the adjustments below were made
    to Mr. Erb&#x2019;s and Mr. Jaramillo&#x2019;s total compensation.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;div id="xdx_23A_zrcTBzf3Km44" style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"&gt;&lt;p id="xdx_23F_zF1aDwb3eo4i" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"&gt;24&#160;&lt;/p&gt;&lt;/div&gt;
    &lt;div id="xdx_23A_zjLLQlNQ7SE5" style="page-break-before: always; margin-top: 6pt"&gt;&lt;p style="margin: 0pt"&gt;&#160;&lt;/p&gt;&lt;/div&gt;
    &lt;div&gt;&lt;div id="xdx_845_eecd--AdjToPeoCompFnTextBlock_dU_zMHImJKNF0Q4" style="margin: 36pt auto 0; width: 468pt; height: 662pt"&gt;


&lt;table cellpadding="0" cellspacing="0" id="xdx_303_zUqvZcY2xOP8" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Pay vs Performance Disclosure"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"&gt;&lt;b&gt;Year&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"&gt;&lt;b&gt;Reported
                                         Summary Compensation Table Total for PEO ($)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"&gt;&lt;b&gt;Less&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"&gt;&lt;b&gt;Reported
                                         Value of Equity Awards ($)&lt;sup&gt;(a)&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"&gt;&lt;b&gt;Plus&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"&gt;&lt;b&gt;Equity
                                         Award Adjustments ($)&lt;sup&gt;(b)&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"&gt;&lt;b&gt;Equals&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"&gt;&lt;b&gt;CAP
                                         for PEO ($)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td colspan="30" style="font-weight: bold"&gt;Mr. Jaramillo&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 15%; text-align: left"&gt;2025&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eecd--PeoTotalCompAmt_c20250101__20251231__ecd--IndividualAxis__custom--MrJaramilloMember_zUfMUeHfTWAj" style="width: 9%; text-align: right"&gt;324,328&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; font-weight: bold; text-align: right"&gt;-&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eecd--AdjToCompAmt_d0_c20250101__20251231__ecd--IndividualAxis__custom--MrJaramilloMember__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--ReportedValueOfEquityAwardsMember_fKGEp_z3J3ykO5Ts2h" style="width: 9%; font-weight: bold; text-align: right"&gt;-&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;+&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eecd--AdjToCompAmt_d0_c20250101__20251231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--EqtyAwrdsAdjsMember__ecd--IndividualAxis__custom--MrJaramilloMember_fKGIp_zN0P1tzQd1s4" style="width: 9%; font-weight: bold; text-align: right"&gt;-&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;=&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eecd--PeoActuallyPaidCompAmt_c20250101__20251231__ecd--IndividualAxis__custom--MrJaramilloMember_zOCGqnf948S1" style="width: 9%; text-align: right"&gt;324,328&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;2024&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eecd--PeoTotalCompAmt_c20240101__20241231__ecd--IndividualAxis__custom--MrJaramilloMember_zenqO9ewdUwd" style="text-align: right"&gt;409,408&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;-&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eecd--AdjToCompAmt_d0_c20240101__20241231__ecd--IndividualAxis__custom--MrJaramilloMember__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--ReportedValueOfEquityAwardsMember_fKGEp_zlM74AfRKMdf" style="font-weight: bold; text-align: right"&gt;-&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;+&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eecd--AdjToCompAmt_c20240101__20241231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--EqtyAwrdsAdjsMember__ecd--IndividualAxis__custom--MrJaramilloMember_fKGIp_z9qzd5WUsFlk" style="text-align: right"&gt;(21,547&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;=&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eecd--PeoActuallyPaidCompAmt_c20240101__20241231__ecd--IndividualAxis__custom--MrJaramilloMember_z2TMXcStGeWj" style="text-align: right"&gt;387,861&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;2023&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eecd--PeoTotalCompAmt_c20230101__20231231__ecd--IndividualAxis__custom--MrJaramilloMember_zNfrGkDOqt0e" style="text-align: right"&gt;606,603&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;-&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eecd--AdjToCompAmt_c20230101__20231231__ecd--IndividualAxis__custom--MrJaramilloMember__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--ReportedValueOfEquityAwardsMember_fKGEp_zPPvr7WtISsf" style="text-align: right"&gt;168,891&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;+&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--EqtyAwrdsAdjsMember__ecd--IndividualAxis__custom--MrJaramilloMember_fKGIp_ziBU3OyxPVSh" style="text-align: right"&gt;(14,053&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;=&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eecd--PeoActuallyPaidCompAmt_c20230101__20231231__ecd--IndividualAxis__custom--MrJaramilloMember_zWdRyx7qWFZh" style="text-align: right"&gt;423,659&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td colspan="30" style="font-weight: bold"&gt;Mr. Erb&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;2025&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eecd--PeoTotalCompAmt_c20250101__20251231__ecd--IndividualAxis__custom--MrErbMember_z9NPEoGUX48k" style="text-align: right"&gt;336,180&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;-&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eecd--AdjToCompAmt_c20250101__20251231__ecd--IndividualAxis__custom--MrErbMember__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--ReportedValueOfEquityAwardsMember_fKGEp_zQ8GbzlwrUag" style="text-align: right"&gt;24,897&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;+&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eecd--AdjToCompAmt_c20250101__20251231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--EqtyAwrdsAdjsMember__ecd--IndividualAxis__custom--MrErbMember_fKGIp_zjbX6SFmRGa6" style="text-align: right"&gt;2,040&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;=&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eecd--PeoActuallyPaidCompAmt_c20250101__20251231__ecd--IndividualAxis__custom--MrErbMember_zLWdCVyn5ODf" style="text-align: right"&gt;313,320&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 4%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"&gt;&lt;sup id="xdx_F08_zfWg20CBiiA5"&gt;(a)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 96%"&gt;&lt;span id="xdx_F10_zcfvgbdKqKq9" style="font-family: Times New Roman, Times, Serif; font-size: 8pt"&gt;Amounts
    reflect the grant date fair value of equity awards as reported in the &#x201c;Option Awards&#x201d; column in the Summary Compensation
    Table for the applicable year.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"&gt;&lt;sup id="xdx_F08_zv3h3zLxzhR3"&gt;(b)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span id="xdx_F19_zKd02rM0iQij" style="font-family: Times New Roman, Times, Serif; font-size: 8pt"&gt;The
                                         equity award adjustments were calculated in accordance with Item 402(v) of Regulation
                                         S-K and include: (i) the year-end fair value of any equity awards granted in the applicable
                                         year that are outstanding and unvested as of the end of the year; (ii) the amount of
                                         change as of the end of the applicable year (from the end of the prior fiscal year) in
                                         fair value of any awards granted in prior years that are outstanding and unvested as
                                         of the end of the applicable year; (iii) for awards that are granted in the applicable
                                         year and vest in the same year, the fair value as of the vesting date;(iv) for awards
                                         granted in prior years that vest in the applicable year, the amount equal to the change
                                         as of the vesting date (from the end of the prior fiscal year) in fair value; (v) for
                                         awards granted in prior years that are determined to fail to meet the applicable vesting
                                         conditions during the applicable year, a deduction for the amount equal to the fair value
                                         at the end of the prior fiscal year; and (vi) the dollar value of any dividends or other
                                         earnings paid on stock or option awards in the applicable year prior to the vesting date
                                         that are not otherwise reflected in the fair value of such award or included in any other
                                         component of total compensation for the applicable year. The valuation assumptions used
                                         to calculate fair values did not materially differ from those disclosed at the time of
                                         grant. The amounts deducted or added in calculating the equity award adjustments for
                                         each of Mr. Erb and Mr. Jaramillo for the years in which they served as PEO are as follows:&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_304_zdUrB4WxNKTf" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Pay vs Performance Disclosure"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"&gt;&lt;b&gt;Year&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&lt;p style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"&gt;&lt;b&gt;Year
                                         End Fair Value of Equity Awards Granted in the Year and Outstanding and Unvested at Year
                                         End ($)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&lt;p style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"&gt;&lt;b&gt;Year
                                         over Year Change in Fair Value of Outstanding and Unvested Equity Awards ($)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&lt;p style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"&gt;&lt;b&gt;Fair
                                         Value as of Vesting Date of Equity Awards Granted and Vested in the Year ($)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&lt;p style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"&gt;&lt;b&gt;Change
                                         in Fair Value to the Vesting Date of Equity Awards Granted in Prior Years that Vested
                                         in the Year ($)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&lt;p style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"&gt;&lt;b&gt;Fair
                                         Value at the End of the Prior Year of Equity Awards that Failed to Meet Vesting Conditions
                                         in the Year ($)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&lt;p style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"&gt;&lt;b&gt;Value
                                         of Dividends or Other Earnings Paid on Stock or Option Awards Not Otherwise Reflected
                                         in Fair Value or Total Compensation ($)&lt;/b&gt;&lt;/span&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&lt;p style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"&gt;&lt;b&gt;Total
                                         Equity Award Adjustments ($)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td colspan="30" style="font-weight: bold"&gt;Mr. Jaramillo&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 15%; text-align: left"&gt;2025&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eecd--AdjToCompAmt_d0_c20250101__20251231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember__ecd--IndividualAxis__custom--MrJaramilloMember_zDSjcfLuVY9h" style="width: 9%; font-weight: bold; text-align: right"&gt;-&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eecd--AdjToCompAmt_d0_c20250101__20251231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember__ecd--IndividualAxis__custom--MrJaramilloMember_zr39mWjptHKg" style="width: 9%; font-weight: bold; text-align: right"&gt;-&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eecd--AdjToCompAmt_c20250101__20251231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember__ecd--IndividualAxis__custom--MrJaramilloMember_z0h29Pfy95g6" style="width: 9%; text-align: right"&gt;0&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eecd--AdjToCompAmt_d0_c20250101__20251231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember__ecd--IndividualAxis__custom--MrJaramilloMember_zqewGiBnG3N6" style="width: 9%; font-weight: bold; text-align: right"&gt;-&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eecd--AdjToCompAmt_d0_c20250101__20251231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember__ecd--IndividualAxis__custom--MrJaramilloMember_zPtYr0AMYLua" style="width: 9%; font-weight: bold; text-align: right"&gt;-&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eecd--AdjToCompAmt_c20250101__20251231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember__ecd--IndividualAxis__custom--MrJaramilloMember_zzS33VQjWz7j" style="width: 9%; text-align: right"&gt;0&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eecd--AdjToCompAmt_d0_c20250101__20251231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember__ecd--IndividualAxis__custom--MrJaramilloMember_zmjfqsHNJJgg" style="width: 9%; font-weight: bold; text-align: right"&gt;-&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;2024&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eecd--AdjToCompAmt_d0_c20240101__20241231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember__ecd--IndividualAxis__custom--MrJaramilloMember_zibcIuGIa7J2" style="font-weight: bold; text-align: right"&gt;-&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eecd--AdjToCompAmt_c20240101__20241231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember__ecd--IndividualAxis__custom--MrJaramilloMember_zsHuZgeuOtLk" style="text-align: right"&gt;(9,977&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eecd--AdjToCompAmt_c20240101__20241231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember__ecd--IndividualAxis__custom--MrJaramilloMember_zU4tYRIk9mhh" style="text-align: right"&gt;0&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eecd--AdjToCompAmt_c20240101__20241231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember__ecd--IndividualAxis__custom--MrJaramilloMember_zrpr6eSuMm3b" style="text-align: right"&gt;(1,254&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eecd--AdjToCompAmt_c20240101__20241231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember__ecd--IndividualAxis__custom--MrJaramilloMember_z73O5cCFIhI8" style="text-align: right"&gt;(10,316&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eecd--AdjToCompAmt_c20240101__20241231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember__ecd--IndividualAxis__custom--MrJaramilloMember_zJ5bD5PoTkx9" style="text-align: right"&gt;0&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eecd--AdjToCompAmt_c20240101__20241231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember__ecd--IndividualAxis__custom--MrJaramilloMember_zhz4OkrNazPj" style="text-align: right"&gt;(21,547&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;2023&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember__ecd--IndividualAxis__custom--MrJaramilloMember_zKHGkOboTVrj" style="text-align: right"&gt;9,813&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember__ecd--IndividualAxis__custom--MrJaramilloMember_zyuZg7T4oIo" style="text-align: right"&gt;(9,665&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember__ecd--IndividualAxis__custom--MrJaramilloMember_zJbPO2dAhtIa" style="text-align: right"&gt;0&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember__ecd--IndividualAxis__custom--MrJaramilloMember_zQ9meqcftTub" style="text-align: right"&gt;(4,270&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember__ecd--IndividualAxis__custom--MrJaramilloMember_zxpmaPSDfzKh" style="text-align: right"&gt;(9,931&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember__ecd--IndividualAxis__custom--MrJaramilloMember_zHUS6ofHMZE6" style="text-align: right"&gt;0&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember__ecd--IndividualAxis__custom--MrJaramilloMember_zEaeYt7BumL2" style="text-align: right"&gt;(14,053&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td colspan="30" style="font-weight: bold"&gt;Mr. Erb&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;2025&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eecd--AdjToCompAmt_d0_c20250101__20251231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember__ecd--IndividualAxis__custom--MrErbMember_zZdCW56fg6a3" style="text-align: right"&gt;2,040&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eecd--AdjToCompAmt_d0_c20250101__20251231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember__ecd--IndividualAxis__custom--MrErbMember_zbIn14qJbpfe" style="font-weight: bold; text-align: right"&gt;-&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eecd--AdjToCompAmt_c20250101__20251231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember__ecd--IndividualAxis__custom--MrErbMember_zfxBfBIkySJk" style="text-align: right"&gt;0&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eecd--AdjToCompAmt_d0_c20250101__20251231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember__ecd--IndividualAxis__custom--MrErbMember_zMhWjzpJkXQ7" style="font-weight: bold; text-align: right"&gt;-&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eecd--AdjToCompAmt_d0_c20250101__20251231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember__ecd--IndividualAxis__custom--MrErbMember_zpu0KW5cOCq8" style="font-weight: bold; text-align: right"&gt;-&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eecd--AdjToCompAmt_c20250101__20251231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember__ecd--IndividualAxis__custom--MrErbMember_zbNk4BQJcQU1" style="text-align: right"&gt;0&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eecd--AdjToCompAmt_c20250101__20251231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember__ecd--IndividualAxis__custom--MrErbMember_zCObwn1Wski2" style="text-align: right"&gt;2,040&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;


&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 4%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"&gt;&lt;sup&gt;(3)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 96%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"&gt;Reflects
    the average amount reported in the &#x201c;Total&#x201d; column of the Summary Compensation Table for our other NEOs as a group
    (excluding Mr. Erb and Mr. Jaramillo) for each corresponding year. See &#x201c;Named Executive Officer Compensation Tables
    - Summary Compensation Table for 2025 and 2024&#x201d; and &#x201c;Named Executive Officer Compensation Tables - Summary Compensation
    Table for 2024 and 2023&#x201d; in our 2025 Definitive Proxy Statement filed with the SEC on April 14, 2025. The names of each
    of the other NEOs (excluding Mr. Erb and Mr. Jaramillo) Included for purposes of calculating the average amounts in each applicable
    year are Mr. Ayotte, Ms. Blake, and Mr. Scott for 2023, Mr. Ayotte and Mr. Scott for 2024, and Mr. Ayotte and Mr. Scott for
    2025. Since Ms. Blake and Mr. Scott served as Chief Financial Officer for a portion of 2023 and Mr. Scott served as Chief
    Financial Officer for a portion of 2025, the compensation of each such non-PEO NEO has been included for purposes of calculating
    the average summary compensation table total in each respective year. In addition to serving as our PEO, Mr. Erb served as
    Interim Chief Financial Officer for a portion of 2025 and did not receive any additional compensation for serving in this
    role during the applicable year. Mr. Erb&#x2019;s compensation for 2025 has not been included for purposes of calculating the
    average summary compensation total in that year.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;

&lt;/div&gt;&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 4%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"&gt;&lt;sup&gt;(4)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 96%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"&gt;Amounts
    reported reflect CAP for the other NEOs as a group (excluding Mr. Erb and Mr. Jaramillo), as computed in accordance with Item
    402(v) of Regulation S- K, for each corresponding year, which amounts reflect an average of the actual amount of compensation
    earned by or paid to the other NEOs as a group (excluding Mr. Erb and Mr. Jaramillo) during the applicable year. The adjustments
    below were made to the average total compensation for the NEOs as a group (excluding Mr. Erb and Mr. Jaramillo) for each year
    to determine the CAP for such year. Since both Ms. Blake and Mr. Scott served as Chief Financial Officer for a portion of
    2023, and Mr. Scott served as Chief Financial Officer for a portion of 2025, these two non-PEO NEOs have been treated as one
    full-time equivalent individual for purposes of calculating the average compensation actually paid to non-PEO NEOs in each
    respective year. In addition to serving as our PEO, Mr. Erb served as Interim Chief Financial Officer for a portion of 2025
    and did not receive any additional compensation for serving in this role during the applicable year.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_844_eecd--AdjToNonPeoNeoCompFnTextBlock_dU_zIjdQLQEJAEc" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;
&lt;table cellpadding="0" cellspacing="0" id="xdx_305_zZMNMFwQQ82f" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Pay vs Performance Disclosure"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"&gt;&lt;b&gt;Year&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;Average Reported
    Summary Compensation Table Total for Non-PEO NEOs ($)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;Less&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;Average Reported
    Value of Equity Awards ($)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;Plus&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"&gt;&lt;b&gt;Average
                                         Equity Award Adjustments &lt;br/&gt;
($)&lt;sup&gt;(a)&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;Equals&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;p style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"&gt;&lt;b&gt;Average
                                         CAP for Non-PEO NEOs &lt;br/&gt;
($)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 12%; text-align: left"&gt;2025&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_985_eecd--NonPeoNeoAvgTotalCompAmt_dxL_c20250101__20251231_zc7DlOcNnAM2" style="width: 12%; text-align: right" title="::XDX::306100"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0136"&gt;306,099&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 12%; font-weight: bold; text-align: center"&gt;-&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_989_eecd--AdjToCompAmt_d0_c20250101__20251231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--EqtyAwrdsInSummryCompstnTblForAplblYrMember_zxEZLTEGJYGi" style="width: 12%; font-weight: bold; text-align: center"&gt;-&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 12%; text-align: center"&gt;+&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_983_eecd--AdjToCompAmt_d0_c20250101__20251231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember_fKGEp_zplNSDXOaIAl" style="width: 11%; font-weight: bold; text-align: center"&gt;-&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 11%; text-align: center"&gt;=&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_981_eecd--NonPeoNeoAvgCompActuallyPaidAmt_dxL_c20250101__20251231_zHzEdYJplPPh" style="width: 11%; text-align: center" title="::XDX::306100"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0139"&gt;306,099&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_982_eecd--NonPeoNeoAvgTotalCompAmt_c20240101__20241231_z3hnFYVZowM2" style="text-align: right"&gt;288,472&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;-&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_985_eecd--AdjToCompAmt_d0_c20240101__20241231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--EqtyAwrdsInSummryCompstnTblForAplblYrMember_zpJRwiKH2I6a" style="font-weight: bold; text-align: center"&gt;-&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;+&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98D_eecd--AdjToCompAmt_c20240101__20241231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember_fKGEp_zzAwxvlhKjoe" style="text-align: center"&gt;(16,542)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;=&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98A_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20240101__20241231_zLhjeoA7SKsc" style="text-align: center"&gt;271,930&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98F_eecd--NonPeoNeoAvgTotalCompAmt_dxL_c20230101__20231231_ztSc5yX6Zsm" style="text-align: right" title="::XDX::446458"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0144"&gt;297,639&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;-&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_981_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--EqtyAwrdsInSummryCompstnTblForAplblYrMember_z7DjYdx9w0wi" style="text-align: center"&gt;97,176&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;+&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_986_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember_fKGEp_zCAHZ30OFov1" style="text-align: center"&gt;1,903&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;=&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_989_eecd--NonPeoNeoAvgCompActuallyPaidAmt_dxL_c20230101__20231231_zrmLs5YXjQEl" style="text-align: center" title="::XDX::351185"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0147"&gt;202,366&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 4%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"&gt;&lt;sup id="xdx_F01_zlAQ0Yl1zqD3"&gt;(a)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left; width: 96%"&gt;&lt;span id="xdx_F1C_zbgrviJYUvSk" style="font-family: Times New Roman, Times, Serif; font-size: 8pt"&gt;See
                                         note (b) to footnote (2) above for an explanation of the equity award adjustments made
                                         in accordance with Item 402(v) of Regulation S-K. The amounts deducted or added in calculating
                                         the total average equity award adjustments for the other NEOs as a group (excluding Mr.
                                         Erb and Mr. Jaramillo) are as follows:&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0in; text-indent: 0.5in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
&lt;table cellpadding="0" cellspacing="0" id="xdx_30F_zaPOFVMRpDT7" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Pay vs Performance Disclosure"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"&gt;&lt;b&gt;Year&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"&gt;&lt;b&gt;Average
                                         Year End Fair Value of Equity Awards Granted in the Year and Outstanding and Unvested
                                         at Year End&lt;/b&gt;&lt;/span&gt;&lt;span style="font-size: 8pt"&gt;&lt;br/&gt; &lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;Year over Year
    Average Change in Fair Value of Outstanding and Unvested Equity Awards&lt;br/&gt; ($)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;Average Fair
    Value as of Vesting Date of Equity Awards Granted and Vested in the Year&lt;br/&gt; ($)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;Average Change
    in Fair Value to the Vesting Date of Equity Awards Granted in Prior Years that Vested in the Year&lt;br/&gt; ($)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;Average Fair
    Value at the End of the Prior Year of Equity Awards that Failed to Meet Vesting Conditions in the Year&lt;br/&gt; ($)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;Average Value
    of Dividends or Other Earnings Paid on Stock or Option Awards not Otherwise Reflected in Fair Value or Total Compensation&lt;br/&gt;
    ($)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;Total Average
    Equity Award Adjustments&lt;br/&gt; ($)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 12%; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eecd--AdjToCompAmt_d0_c20250101__20251231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_zHoVgd3rFLF3" style="width: 12%; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eecd--AdjToCompAmt_d0_c20250101__20251231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_zSBVx4AOl4uh" style="width: 12%; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eecd--AdjToCompAmt_c20250101__20251231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_zSPePhvKBaGl" style="width: 12%; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eecd--AdjToCompAmt_d0_c20250101__20251231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_zMk6Fznvez91" style="width: 12%; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eecd--AdjToCompAmt_d0_c20250101__20251231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_zmo31xGAunWl" style="width: 11%; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eecd--AdjToCompAmt_c20250101__20251231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_zMdarFrO85z3" style="width: 11%; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eecd--AdjToCompAmt_d0_c20250101__20251231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember_zyJB2gxIUkfj" style="width: 11%; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eecd--AdjToCompAmt_d0_c20240101__20241231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_zO8z9WJLEZGd" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eecd--AdjToCompAmt_c20240101__20241231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_zLsJYh5M1Hdd" style="text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;(6,517)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eecd--AdjToCompAmt_c20240101__20241231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_zFigXYiszBIl" style="text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eecd--AdjToCompAmt_c20240101__20241231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_zoXaREJuz8wk" style="text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;(3,255)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eecd--AdjToCompAmt_c20240101__20241231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_zsQNsixgLkxg" style="text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;(6,770)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eecd--AdjToCompAmt_c20240101__20241231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_zV7Wc9BGfRWd" style="text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eecd--AdjToCompAmt_c20240101__20241231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember_zbBNUlR1fCvi" style="text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;(16,542)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_zudq02CBEk7b" style="text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;6,481&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_zZLXDZlp6Fih" style="text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;(1,452)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_zmw8Xn24C2Sk" style="text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_zJCaOuTdJfEb" style="text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;(1,633)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_zq79ZUR0ZIPh" style="text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;(1,493)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_zpYVQMR5h9l8" style="text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember_zjq2sjiMJsUa" style="text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;1,903&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 4%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"&gt;&lt;sup&gt;(5)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 96%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"&gt;The
    amounts reported in this column represent the Company&#x2019;s cumulative TSR, which is calculated by dividing the sum of the
    cumulative amount of dividends for the measurement period, assuming dividend reinvestment, and the difference between the
    Company&#x2019;s share price at the end of the measurement period and the beginning of the measurement period by the Company&#x2019;s
    share price at the beginning of the measurement period.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 4%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"&gt;&lt;sup&gt;(6)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 96%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"&gt;The
    amounts reported in this column represent net income reflected in the Company&#x2019;s audited financial statements for the
    applicable year.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p id="xdx_851_z95cGiBaRdxl" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

</ecd:PvpTableTextBlock>
    <ecd:PeoTotalCompAmt
      contextRef="From2025-01-012025-12-31_custom_MrJaramilloMember"
      decimals="0"
      id="Fact000027"
      unitRef="USD">324328</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="From2025-01-012025-12-31_custom_MrJaramilloMember"
      decimals="0"
      id="Fact000029"
      unitRef="USD">324328</ecd:PeoActuallyPaidCompAmt>
    <ecd:PeoTotalCompAmt
      contextRef="From2025-01-012025-12-31_custom_MrErbMember"
      decimals="0"
      id="Fact000031"
      unitRef="USD">336180</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="From2025-01-012025-12-31_custom_MrErbMember"
      decimals="0"
      id="Fact000033"
      unitRef="USD">313320</ecd:PeoActuallyPaidCompAmt>
    <ecd:PeoTotalCompAmt
      contextRef="From2024-01-012024-12-31_custom_MrJaramilloMember"
      decimals="0"
      id="Fact000035"
      unitRef="USD">409408</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="From2024-01-012024-12-31_custom_MrJaramilloMember"
      decimals="0"
      id="Fact000037"
      unitRef="USD">387861</ecd:PeoActuallyPaidCompAmt>
    <ecd:PeoTotalCompAmt
      contextRef="From2024-01-012024-12-31_custom_MrErbMember"
      decimals="0"
      id="Fact000039"
      unitRef="USD">-0</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="From2024-01-012024-12-31_custom_MrErbMember"
      decimals="0"
      id="Fact000041"
      unitRef="USD">-0</ecd:PeoActuallyPaidCompAmt>
    <ecd:PeoTotalCompAmt
      contextRef="From2023-01-012023-12-31_custom_MrJaramilloMember"
      decimals="0"
      id="Fact000043"
      unitRef="USD">606603</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="From2023-01-012023-12-31_custom_MrJaramilloMember"
      decimals="0"
      id="Fact000045"
      unitRef="USD">423659</ecd:PeoActuallyPaidCompAmt>
    <ecd:PeoTotalCompAmt
      contextRef="From2023-01-012023-12-31_custom_MrErbMember"
      decimals="0"
      id="Fact000047"
      unitRef="USD">-0</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="From2023-01-012023-12-31_custom_MrErbMember"
      decimals="0"
      id="Fact000049"
      unitRef="USD">-0</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="From2025-01-01to2025-12-31"
      decimals="0"
      id="Fact000051"
      unitRef="USD">306100</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="From2025-01-01to2025-12-31"
      decimals="0"
      id="Fact000053"
      unitRef="USD">306100</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt
      contextRef="From2025-01-01to2025-12-31"
      decimals="2"
      id="Fact000055"
      unitRef="USD">0.17</ecd:TotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss
      contextRef="From2025-01-01to2025-12-31"
      decimals="0"
      id="Fact000057"
      unitRef="USD">17521000</us-gaap:NetIncomeLoss>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="From2024-01-012024-12-31"
      decimals="0"
      id="Fact000059"
      unitRef="USD">288472</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="From2024-01-012024-12-31"
      decimals="0"
      id="Fact000061"
      unitRef="USD">271930</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt
      contextRef="From2024-01-012024-12-31"
      decimals="2"
      id="Fact000063"
      unitRef="USD">0.03</ecd:TotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss
      contextRef="From2024-01-012024-12-31"
      decimals="0"
      id="Fact000065"
      unitRef="USD">11165000</us-gaap:NetIncomeLoss>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000067"
      unitRef="USD">446458</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000069"
      unitRef="USD">351185</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt
      contextRef="From2023-01-012023-12-31"
      decimals="2"
      id="Fact000071"
      unitRef="USD">0.47</ecd:TotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss
      contextRef="From2023-01-012023-12-31"
      decimals="0"
      id="Fact000073"
      unitRef="USD">20209000</us-gaap:NetIncomeLoss>
    <ecd:NamedExecutiveOfficersFnTextBlock contextRef="From2025-01-01to2025-12-31" id="Fact000075">&lt;p id="xdx_84D_eecd--NamedExecutiveOfficersFnTextBlock_dU_zhrvPZU1UD97" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 4%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"&gt;&lt;sup id="xdx_F0E_zWYc8phxWyq"&gt;(1)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 96%"&gt;&lt;span id="xdx_F1B_zIEL5hdMfia3" style="font-family: Times New Roman, Times, Serif; font-size: 8pt"&gt;Reflects
    the amount reported in the &#x201c;Total&#x201d; column of the Summary Compensation Table for each of &lt;span id="xdx_90B_eecd--PeoName_c20250101__20251231__ecd--IndividualAxis__custom--MrErbMember_zf1sFgyp6Dua"&gt;Mr. Erb&lt;/span&gt; and &lt;span id="xdx_904_eecd--PeoName_c20230101__20231231__ecd--IndividualAxis__custom--MrJaramilloMember_zPUdSol0ZkZ5"&gt;&lt;span id="xdx_901_eecd--PeoName_c20240101__20241231__ecd--IndividualAxis__custom--MrJaramilloMember_zUxUINMYfZj3"&gt;&lt;span id="xdx_904_eecd--PeoName_c20250101__20250228__ecd--IndividualAxis__custom--MrJaramilloMember_zpuUh1Zryfi3"&gt;Mr. Jaramillo&lt;/span&gt;&lt;/span&gt;&lt;/span&gt;
    for each corresponding year in which they served as PEO. Mr. Jaramillo was our PEO from 2023 to February 2025, and Mr. Erb
    was our PEO from February 2025 to December 2025. The amount reported in the &#x201c;Total&#x201d; column of the Summary Compensation
    Table for Mr. Jaramillo includes $224,561.19 of Separation Pay in 2025. The amount reported in the &#x201c;Total&#x201d; column
    of the Summary Compensation Table for Mr. Erb includes $49,300 and $8,036 of compensation for service as Chairman of the Board
    in 2024 and 2025, respectively. See &#x201c;Named Executive Officer Compensation Tables - Summary Compensation Table for 2025
    and 2024&#x201d; and &#x201c;Named Executive Officer Compensation Tables - Summary Compensation Table for 2024 and 2023&#x201d;
    in our 2025 Definitive Proxy Statement filed with the SEC on April 14, 2025.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"&gt;
&lt;tr style="display: none; vertical-align: top; text-align: left; visibility: hidden"&gt;
  &lt;td style="display: none; width: 3%; visibility: hidden"&gt;&lt;sup id="xdx_F0B_zBGw0qcxpo76"&gt;(2)&lt;/sup&gt;&lt;/td&gt;
  &lt;td id="xdx_F17_zcVeNnZdl3C8" style="display: none; width: 97%; visibility: hidden"&gt;The amounts reported in this column represent CAP for Mr. Erb and Mr. Jaramillo for each corresponding year in which they served as PEO
computed as required by Item 402(v) of Regulation S-K. The reported amounts do not reflect the actual compensation earned by or paid to
Mr. Erb or Mr. Jaramillo during any applicable year. To determine CAP, the adjustments below were made to Mr. Erb&#x2019;s and Mr. Jaramillo&#x2019;s
total compensation.&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="display: none; vertical-align: top; text-align: left; visibility: hidden"&gt;
  &lt;td style="display: none; visibility: hidden"&gt;&lt;sup id="xdx_F01_zJcZsZXnDS24"&gt;(3)&lt;/sup&gt;&lt;/td&gt;
  &lt;td id="xdx_F1D_zDid4KryHas6" style="display: none; visibility: hidden"&gt;Reflects the average amount reported in the &#x201c;Total&#x201d; column of the Summary Compensation Table for our other NEOs as a group
(excluding Mr. Erb and Mr. Jaramillo) for each corresponding year. See &#x201c;Named Executive Officer Compensation Tables - Summary Compensation
Table for 2025 and 2024&#x201d; and &#x201c;Named Executive Officer Compensation Tables - Summary Compensation Table for 2024 and 2023&#x201d;
in our 2025 Definitive Proxy Statement filed with the SEC on April 14, 2025. The names of each of the other NEOs (excluding Mr. Erb and
Mr. Jaramillo) Included for purposes of calculating the average amounts in each applicable year are Mr. Ayotte, Ms. Blake, and Mr. Scott
for 2023, Mr. Ayotte and Mr. Scott for 2024, and Mr. Ayotte and Mr. Scott for 2025. Since Ms. Blake and Mr. Scott served as Chief Financial
Officer for a portion of 2023 and Mr. Scott served as Chief Financial Officer for a portion of 2025, the compensation of each such non-PEO
NEO has been included for purposes of calculating the average summary compensation table total in each respective year. In addition to
serving as our PEO, Mr. Erb served as Interim Chief Financial Officer for a portion of 2025 and did not receive any additional compensation
for serving in this role during the applicable year. Mr. Erb&#x2019;s compensation for 2025 has not been included for purposes of calculating
the average summary compensation total in that year.&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="display: none; vertical-align: top; text-align: left; visibility: hidden"&gt;
  &lt;td style="display: none; visibility: hidden"&gt;&lt;sup id="xdx_F09_zijKcgYdRyxk"&gt;(4)&lt;/sup&gt;&lt;/td&gt;
  &lt;td id="xdx_F1F_zCcdskAICmfe" style="display: none; visibility: hidden"&gt;Amounts reported reflect CAP for the other NEOs as a group (excluding Mr. Erb and Mr. Jaramillo), as computed in accordance with Item
402(v) of Regulation S- K, for each corresponding year, which amounts reflect an average of the actual amount of compensation earned by
or paid to the other NEOs as a group (excluding Mr. Erb and Mr. Jaramillo) during the applicable year. The adjustments below were made
to the average total compensation for the NEOs as a group (excluding Mr. Erb and Mr. Jaramillo) for each year to determine the CAP for
such year. Since both Ms. Blake and Mr. Scott served as Chief Financial Officer for a portion of 2023, and Mr. Scott served as Chief Financial
Officer for a portion of 2025, these two non-PEO NEOs have been treated as one full-time equivalent individual for purposes of calculating
the average compensation actually paid to non-PEO NEOs in each respective year. In addition to serving as our PEO, Mr. Erb served as Interim
Chief Financial Officer for a portion of 2025 and did not receive any additional compensation for serving in this role during the applicable
year.&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="display: none; vertical-align: top; text-align: left; visibility: hidden"&gt;
  &lt;td style="display: none; visibility: hidden"&gt;&lt;sup id="xdx_F01_z3SyGnIFlie8"&gt;(5)&lt;/sup&gt;&lt;/td&gt;
  &lt;td id="xdx_F19_z9OAM0UIGHx9" style="display: none; visibility: hidden"&gt;The amounts reported in this column represent the Company&#x2019;s cumulative TSR, which is calculated by dividing the sum of the cumulative
amount of dividends for the measurement period, assuming dividend reinvestment, and the difference between the Company&#x2019;s share price
at the end of the measurement period and the beginning of the measurement period by the Company&#x2019;s share price at the beginning of
the measurement period.&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="display: none; vertical-align: top; text-align: left; visibility: hidden"&gt;
  &lt;td style="display: none; visibility: hidden"&gt;&lt;sup id="xdx_F01_zYEjJKfWFnLh"&gt;(6)&lt;/sup&gt;&lt;/td&gt;
  &lt;td id="xdx_F1F_z4E7oRTnEPi5" style="display: none; visibility: hidden"&gt;The amounts reported in this column represent net income reflected in the Company&#x2019;s audited financial statements for the applicable
year.&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</ecd:NamedExecutiveOfficersFnTextBlock>
    <ecd:PeoName
      contextRef="From2025-01-012025-12-31_custom_MrErbMember"
      id="Fact000077">Mr. Erb</ecd:PeoName>
    <ecd:PeoName
      contextRef="From2023-01-012023-12-31_custom_MrJaramilloMember"
      id="Fact000078">Mr. Jaramillo</ecd:PeoName>
    <ecd:PeoName
      contextRef="From2024-01-012024-12-31_custom_MrJaramilloMember"
      id="Fact000079">Mr. Jaramillo</ecd:PeoName>
    <ecd:PeoName
      contextRef="From2025-01-012025-02-28_custom_MrJaramilloMember"
      id="Fact000080">Mr. Jaramillo</ecd:PeoName>
    <ecd:AdjToPeoCompFnTextBlock contextRef="From2025-01-01to2025-12-31" id="Fact000087">&lt;div id="xdx_845_eecd--AdjToPeoCompFnTextBlock_dU_zMHImJKNF0Q4" style="margin: 36pt auto 0; width: 468pt; height: 662pt"&gt;


&lt;table cellpadding="0" cellspacing="0" id="xdx_303_zUqvZcY2xOP8" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Pay vs Performance Disclosure"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"&gt;&lt;b&gt;Year&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"&gt;&lt;b&gt;Reported
                                         Summary Compensation Table Total for PEO ($)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"&gt;&lt;b&gt;Less&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"&gt;&lt;b&gt;Reported
                                         Value of Equity Awards ($)&lt;sup&gt;(a)&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"&gt;&lt;b&gt;Plus&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"&gt;&lt;b&gt;Equity
                                         Award Adjustments ($)&lt;sup&gt;(b)&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"&gt;&lt;b&gt;Equals&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"&gt;&lt;b&gt;CAP
                                         for PEO ($)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td colspan="30" style="font-weight: bold"&gt;Mr. Jaramillo&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 15%; text-align: left"&gt;2025&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eecd--PeoTotalCompAmt_c20250101__20251231__ecd--IndividualAxis__custom--MrJaramilloMember_zUfMUeHfTWAj" style="width: 9%; text-align: right"&gt;324,328&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; font-weight: bold; text-align: right"&gt;-&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eecd--AdjToCompAmt_d0_c20250101__20251231__ecd--IndividualAxis__custom--MrJaramilloMember__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--ReportedValueOfEquityAwardsMember_fKGEp_z3J3ykO5Ts2h" style="width: 9%; font-weight: bold; text-align: right"&gt;-&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;+&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eecd--AdjToCompAmt_d0_c20250101__20251231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--EqtyAwrdsAdjsMember__ecd--IndividualAxis__custom--MrJaramilloMember_fKGIp_zN0P1tzQd1s4" style="width: 9%; font-weight: bold; text-align: right"&gt;-&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 9%; text-align: right"&gt;=&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eecd--PeoActuallyPaidCompAmt_c20250101__20251231__ecd--IndividualAxis__custom--MrJaramilloMember_zOCGqnf948S1" style="width: 9%; text-align: right"&gt;324,328&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;2024&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eecd--PeoTotalCompAmt_c20240101__20241231__ecd--IndividualAxis__custom--MrJaramilloMember_zenqO9ewdUwd" style="text-align: right"&gt;409,408&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;-&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eecd--AdjToCompAmt_d0_c20240101__20241231__ecd--IndividualAxis__custom--MrJaramilloMember__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--ReportedValueOfEquityAwardsMember_fKGEp_zlM74AfRKMdf" style="font-weight: bold; text-align: right"&gt;-&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;+&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eecd--AdjToCompAmt_c20240101__20241231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--EqtyAwrdsAdjsMember__ecd--IndividualAxis__custom--MrJaramilloMember_fKGIp_z9qzd5WUsFlk" style="text-align: right"&gt;(21,547&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;=&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98E_eecd--PeoActuallyPaidCompAmt_c20240101__20241231__ecd--IndividualAxis__custom--MrJaramilloMember_z2TMXcStGeWj" style="text-align: right"&gt;387,861&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;2023&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eecd--PeoTotalCompAmt_c20230101__20231231__ecd--IndividualAxis__custom--MrJaramilloMember_zNfrGkDOqt0e" style="text-align: right"&gt;606,603&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;-&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eecd--AdjToCompAmt_c20230101__20231231__ecd--IndividualAxis__custom--MrJaramilloMember__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--ReportedValueOfEquityAwardsMember_fKGEp_zPPvr7WtISsf" style="text-align: right"&gt;168,891&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;+&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--EqtyAwrdsAdjsMember__ecd--IndividualAxis__custom--MrJaramilloMember_fKGIp_ziBU3OyxPVSh" style="text-align: right"&gt;(14,053&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;=&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eecd--PeoActuallyPaidCompAmt_c20230101__20231231__ecd--IndividualAxis__custom--MrJaramilloMember_zWdRyx7qWFZh" style="text-align: right"&gt;423,659&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td colspan="30" style="font-weight: bold"&gt;Mr. Erb&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;2025&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eecd--PeoTotalCompAmt_c20250101__20251231__ecd--IndividualAxis__custom--MrErbMember_z9NPEoGUX48k" style="text-align: right"&gt;336,180&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold; text-align: right"&gt;-&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eecd--AdjToCompAmt_c20250101__20251231__ecd--IndividualAxis__custom--MrErbMember__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__custom--ReportedValueOfEquityAwardsMember_fKGEp_zQ8GbzlwrUag" style="text-align: right"&gt;24,897&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;+&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eecd--AdjToCompAmt_c20250101__20251231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--EqtyAwrdsAdjsMember__ecd--IndividualAxis__custom--MrErbMember_fKGIp_zjbX6SFmRGa6" style="text-align: right"&gt;2,040&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="text-align: right"&gt;=&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_987_eecd--PeoActuallyPaidCompAmt_c20250101__20251231__ecd--IndividualAxis__custom--MrErbMember_zLWdCVyn5ODf" style="text-align: right"&gt;313,320&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 4%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"&gt;&lt;sup id="xdx_F08_zfWg20CBiiA5"&gt;(a)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 96%"&gt;&lt;span id="xdx_F10_zcfvgbdKqKq9" style="font-family: Times New Roman, Times, Serif; font-size: 8pt"&gt;Amounts
    reflect the grant date fair value of equity awards as reported in the &#x201c;Option Awards&#x201d; column in the Summary Compensation
    Table for the applicable year.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"&gt;&lt;sup id="xdx_F08_zv3h3zLxzhR3"&gt;(b)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span id="xdx_F19_zKd02rM0iQij" style="font-family: Times New Roman, Times, Serif; font-size: 8pt"&gt;The
                                         equity award adjustments were calculated in accordance with Item 402(v) of Regulation
                                         S-K and include: (i) the year-end fair value of any equity awards granted in the applicable
                                         year that are outstanding and unvested as of the end of the year; (ii) the amount of
                                         change as of the end of the applicable year (from the end of the prior fiscal year) in
                                         fair value of any awards granted in prior years that are outstanding and unvested as
                                         of the end of the applicable year; (iii) for awards that are granted in the applicable
                                         year and vest in the same year, the fair value as of the vesting date;(iv) for awards
                                         granted in prior years that vest in the applicable year, the amount equal to the change
                                         as of the vesting date (from the end of the prior fiscal year) in fair value; (v) for
                                         awards granted in prior years that are determined to fail to meet the applicable vesting
                                         conditions during the applicable year, a deduction for the amount equal to the fair value
                                         at the end of the prior fiscal year; and (vi) the dollar value of any dividends or other
                                         earnings paid on stock or option awards in the applicable year prior to the vesting date
                                         that are not otherwise reflected in the fair value of such award or included in any other
                                         component of total compensation for the applicable year. The valuation assumptions used
                                         to calculate fair values did not materially differ from those disclosed at the time of
                                         grant. The amounts deducted or added in calculating the equity award adjustments for
                                         each of Mr. Erb and Mr. Jaramillo for the years in which they served as PEO are as follows:&lt;/span&gt;&lt;/p&gt;
        &lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" id="xdx_304_zdUrB4WxNKTf" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Pay vs Performance Disclosure"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td colspan="2" style="border-bottom: Black 1pt solid"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"&gt;&lt;b&gt;Year&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&lt;p style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"&gt;&lt;b&gt;Year
                                         End Fair Value of Equity Awards Granted in the Year and Outstanding and Unvested at Year
                                         End ($)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&lt;p style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"&gt;&lt;b&gt;Year
                                         over Year Change in Fair Value of Outstanding and Unvested Equity Awards ($)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&lt;p style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"&gt;&lt;b&gt;Fair
                                         Value as of Vesting Date of Equity Awards Granted and Vested in the Year ($)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&lt;p style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"&gt;&lt;b&gt;Change
                                         in Fair Value to the Vesting Date of Equity Awards Granted in Prior Years that Vested
                                         in the Year ($)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&lt;p style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"&gt;&lt;b&gt;Fair
                                         Value at the End of the Prior Year of Equity Awards that Failed to Meet Vesting Conditions
                                         in the Year ($)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&lt;p style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"&gt;&lt;b&gt;Value
                                         of Dividends or Other Earnings Paid on Stock or Option Awards Not Otherwise Reflected
                                         in Fair Value or Total Compensation ($)&lt;/b&gt;&lt;/span&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td colspan="3" style="text-align: center"&gt;&lt;p style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"&gt;&lt;b&gt;Total
                                         Equity Award Adjustments ($)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td colspan="30" style="font-weight: bold"&gt;Mr. Jaramillo&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="width: 15%; text-align: left"&gt;2025&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eecd--AdjToCompAmt_d0_c20250101__20251231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember__ecd--IndividualAxis__custom--MrJaramilloMember_zDSjcfLuVY9h" style="width: 9%; font-weight: bold; text-align: right"&gt;-&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eecd--AdjToCompAmt_d0_c20250101__20251231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember__ecd--IndividualAxis__custom--MrJaramilloMember_zr39mWjptHKg" style="width: 9%; font-weight: bold; text-align: right"&gt;-&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eecd--AdjToCompAmt_c20250101__20251231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember__ecd--IndividualAxis__custom--MrJaramilloMember_z0h29Pfy95g6" style="width: 9%; text-align: right"&gt;0&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_981_eecd--AdjToCompAmt_d0_c20250101__20251231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember__ecd--IndividualAxis__custom--MrJaramilloMember_zqewGiBnG3N6" style="width: 9%; font-weight: bold; text-align: right"&gt;-&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eecd--AdjToCompAmt_d0_c20250101__20251231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember__ecd--IndividualAxis__custom--MrJaramilloMember_zPtYr0AMYLua" style="width: 9%; font-weight: bold; text-align: right"&gt;-&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eecd--AdjToCompAmt_c20250101__20251231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember__ecd--IndividualAxis__custom--MrJaramilloMember_zzS33VQjWz7j" style="width: 9%; text-align: right"&gt;0&lt;/td&gt;&lt;td style="width: 1%; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_984_eecd--AdjToCompAmt_d0_c20250101__20251231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember__ecd--IndividualAxis__custom--MrJaramilloMember_zmjfqsHNJJgg" style="width: 9%; font-weight: bold; text-align: right"&gt;-&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;2024&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eecd--AdjToCompAmt_d0_c20240101__20241231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember__ecd--IndividualAxis__custom--MrJaramilloMember_zibcIuGIa7J2" style="font-weight: bold; text-align: right"&gt;-&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eecd--AdjToCompAmt_c20240101__20241231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember__ecd--IndividualAxis__custom--MrJaramilloMember_zsHuZgeuOtLk" style="text-align: right"&gt;(9,977&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_982_eecd--AdjToCompAmt_c20240101__20241231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember__ecd--IndividualAxis__custom--MrJaramilloMember_zU4tYRIk9mhh" style="text-align: right"&gt;0&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eecd--AdjToCompAmt_c20240101__20241231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember__ecd--IndividualAxis__custom--MrJaramilloMember_zrpr6eSuMm3b" style="text-align: right"&gt;(1,254&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eecd--AdjToCompAmt_c20240101__20241231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember__ecd--IndividualAxis__custom--MrJaramilloMember_z73O5cCFIhI8" style="text-align: right"&gt;(10,316&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_980_eecd--AdjToCompAmt_c20240101__20241231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember__ecd--IndividualAxis__custom--MrJaramilloMember_zJ5bD5PoTkx9" style="text-align: right"&gt;0&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98F_eecd--AdjToCompAmt_c20240101__20241231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember__ecd--IndividualAxis__custom--MrJaramilloMember_zhz4OkrNazPj" style="text-align: right"&gt;(21,547&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;2023&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember__ecd--IndividualAxis__custom--MrJaramilloMember_zKHGkOboTVrj" style="text-align: right"&gt;9,813&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_989_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember__ecd--IndividualAxis__custom--MrJaramilloMember_zyuZg7T4oIo" style="text-align: right"&gt;(9,665&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98A_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember__ecd--IndividualAxis__custom--MrJaramilloMember_zJbPO2dAhtIa" style="text-align: right"&gt;0&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember__ecd--IndividualAxis__custom--MrJaramilloMember_zQ9meqcftTub" style="text-align: right"&gt;(4,270&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_988_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember__ecd--IndividualAxis__custom--MrJaramilloMember_zxpmaPSDfzKh" style="text-align: right"&gt;(9,931&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember__ecd--IndividualAxis__custom--MrJaramilloMember_zHUS6ofHMZE6" style="text-align: right"&gt;0&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember__ecd--IndividualAxis__custom--MrJaramilloMember_zEaeYt7BumL2" style="text-align: right"&gt;(14,053&lt;/td&gt;&lt;td style="text-align: left"&gt;)&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td colspan="30" style="font-weight: bold"&gt;Mr. Erb&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;2025&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_985_eecd--AdjToCompAmt_d0_c20250101__20251231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember__ecd--IndividualAxis__custom--MrErbMember_zZdCW56fg6a3" style="text-align: right"&gt;2,040&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98D_eecd--AdjToCompAmt_d0_c20250101__20251231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember__ecd--IndividualAxis__custom--MrErbMember_zbIn14qJbpfe" style="font-weight: bold; text-align: right"&gt;-&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_983_eecd--AdjToCompAmt_c20250101__20251231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember__ecd--IndividualAxis__custom--MrErbMember_zfxBfBIkySJk" style="text-align: right"&gt;0&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eecd--AdjToCompAmt_d0_c20250101__20251231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember__ecd--IndividualAxis__custom--MrErbMember_zMhWjzpJkXQ7" style="font-weight: bold; text-align: right"&gt;-&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98B_eecd--AdjToCompAmt_d0_c20250101__20251231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember__ecd--IndividualAxis__custom--MrErbMember_zpu0KW5cOCq8" style="font-weight: bold; text-align: right"&gt;-&lt;/td&gt;&lt;td style="font-weight: bold; text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_986_eecd--AdjToCompAmt_c20250101__20251231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember__ecd--IndividualAxis__custom--MrErbMember_zbNk4BQJcQU1" style="text-align: right"&gt;0&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;td id="xdx_98C_eecd--AdjToCompAmt_c20250101__20251231__ecd--ExecutiveCategoryAxis__ecd--PeoMember__ecd--AdjToCompAxis__ecd--EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember__ecd--IndividualAxis__custom--MrErbMember_zCObwn1Wski2" style="text-align: right"&gt;2,040&lt;/td&gt;&lt;td style="text-align: left"&gt;&#160;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="font: 8pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;


&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 4%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"&gt;&lt;sup&gt;(3)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 96%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"&gt;Reflects
    the average amount reported in the &#x201c;Total&#x201d; column of the Summary Compensation Table for our other NEOs as a group
    (excluding Mr. Erb and Mr. Jaramillo) for each corresponding year. See &#x201c;Named Executive Officer Compensation Tables
    - Summary Compensation Table for 2025 and 2024&#x201d; and &#x201c;Named Executive Officer Compensation Tables - Summary Compensation
    Table for 2024 and 2023&#x201d; in our 2025 Definitive Proxy Statement filed with the SEC on April 14, 2025. The names of each
    of the other NEOs (excluding Mr. Erb and Mr. Jaramillo) Included for purposes of calculating the average amounts in each applicable
    year are Mr. Ayotte, Ms. Blake, and Mr. Scott for 2023, Mr. Ayotte and Mr. Scott for 2024, and Mr. Ayotte and Mr. Scott for
    2025. Since Ms. Blake and Mr. Scott served as Chief Financial Officer for a portion of 2023 and Mr. Scott served as Chief
    Financial Officer for a portion of 2025, the compensation of each such non-PEO NEO has been included for purposes of calculating
    the average summary compensation table total in each respective year. In addition to serving as our PEO, Mr. Erb served as
    Interim Chief Financial Officer for a portion of 2025 and did not receive any additional compensation for serving in this
    role during the applicable year. Mr. Erb&#x2019;s compensation for 2025 has not been included for purposes of calculating the
    average summary compensation total in that year.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;&lt;/div&gt;

&lt;div id="xdx_23B_zhfGAiHiVwI9" style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"&gt;&lt;p id="xdx_238_zvKY3kUBvSj" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"&gt;25&#160;&lt;/p&gt;&lt;/div&gt;
    &lt;div id="xdx_23F_zltIYrVgkzWh" style="page-break-before: always; margin-top: 6pt"&gt;&lt;p style="margin: 0pt"&gt;&#160;&lt;/p&gt;&lt;/div&gt;
    &lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 4%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"&gt;&lt;sup&gt;(4)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 96%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"&gt;Amounts
    reported reflect CAP for the other NEOs as a group (excluding Mr. Erb and Mr. Jaramillo), as computed in accordance with Item
    402(v) of Regulation S- K, for each corresponding year, which amounts reflect an average of the actual amount of compensation
    earned by or paid to the other NEOs as a group (excluding Mr. Erb and Mr. Jaramillo) during the applicable year. The adjustments
    below were made to the average total compensation for the NEOs as a group (excluding Mr. Erb and Mr. Jaramillo) for each year
    to determine the CAP for such year. Since both Ms. Blake and Mr. Scott served as Chief Financial Officer for a portion of
    2023, and Mr. Scott served as Chief Financial Officer for a portion of 2025, these two non-PEO NEOs have been treated as one
    full-time equivalent individual for purposes of calculating the average compensation actually paid to non-PEO NEOs in each
    respective year. In addition to serving as our PEO, Mr. Erb served as Interim Chief Financial Officer for a portion of 2025
    and did not receive any additional compensation for serving in this role during the applicable year.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</ecd:AdjToPeoCompFnTextBlock>
    <ecd:PeoTotalCompAmt
      contextRef="From2025-01-012025-12-31_custom_MrJaramilloMember"
      decimals="0"
      id="Fact000088"
      unitRef="USD">324328</ecd:PeoTotalCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2025-01-012025-12-31_custom_MrJaramilloMember_ecd_PeoMember_custom_ReportedValueOfEquityAwardsMember"
      decimals="0"
      id="Fact000089"
      unitRef="USD">-0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2025-01-012025-12-31_ecd_PeoMember_ecd_EqtyAwrdsAdjsMember_custom_MrJaramilloMember"
      decimals="0"
      id="Fact000090"
      unitRef="USD">-0</ecd:AdjToCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="From2025-01-012025-12-31_custom_MrJaramilloMember"
      decimals="0"
      id="Fact000091"
      unitRef="USD">324328</ecd:PeoActuallyPaidCompAmt>
    <ecd:PeoTotalCompAmt
      contextRef="From2024-01-012024-12-31_custom_MrJaramilloMember"
      decimals="0"
      id="Fact000092"
      unitRef="USD">409408</ecd:PeoTotalCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2024-01-012024-12-31_custom_MrJaramilloMember_ecd_PeoMember_custom_ReportedValueOfEquityAwardsMember"
      decimals="0"
      id="Fact000093"
      unitRef="USD">-0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2024-01-012024-12-31_ecd_PeoMember_ecd_EqtyAwrdsAdjsMember_custom_MrJaramilloMember"
      decimals="0"
      id="Fact000094"
      unitRef="USD">-21547</ecd:AdjToCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="From2024-01-012024-12-31_custom_MrJaramilloMember"
      decimals="0"
      id="Fact000095"
      unitRef="USD">387861</ecd:PeoActuallyPaidCompAmt>
    <ecd:PeoTotalCompAmt
      contextRef="From2023-01-012023-12-31_custom_MrJaramilloMember"
      decimals="0"
      id="Fact000096"
      unitRef="USD">606603</ecd:PeoTotalCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_custom_MrJaramilloMember_ecd_PeoMember_custom_ReportedValueOfEquityAwardsMember"
      decimals="0"
      id="Fact000097"
      unitRef="USD">168891</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_ecd_PeoMember_ecd_EqtyAwrdsAdjsMember_custom_MrJaramilloMember"
      decimals="0"
      id="Fact000098"
      unitRef="USD">-14053</ecd:AdjToCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="From2023-01-012023-12-31_custom_MrJaramilloMember"
      decimals="0"
      id="Fact000099"
      unitRef="USD">423659</ecd:PeoActuallyPaidCompAmt>
    <ecd:PeoTotalCompAmt
      contextRef="From2025-01-012025-12-31_custom_MrErbMember"
      decimals="0"
      id="Fact000100"
      unitRef="USD">336180</ecd:PeoTotalCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2025-01-012025-12-31_custom_MrErbMember_ecd_PeoMember_custom_ReportedValueOfEquityAwardsMember"
      decimals="0"
      id="Fact000101"
      unitRef="USD">24897</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2025-01-012025-12-31_ecd_PeoMember_ecd_EqtyAwrdsAdjsMember_custom_MrErbMember"
      decimals="0"
      id="Fact000102"
      unitRef="USD">2040</ecd:AdjToCompAmt>
    <ecd:PeoActuallyPaidCompAmt
      contextRef="From2025-01-012025-12-31_custom_MrErbMember"
      decimals="0"
      id="Fact000103"
      unitRef="USD">313320</ecd:PeoActuallyPaidCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2025-01-012025-12-31_ecd_PeoMember_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_custom_MrJaramilloMember"
      decimals="0"
      id="Fact000106"
      unitRef="USD">-0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2025-01-012025-12-31_ecd_PeoMember_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_custom_MrJaramilloMember"
      decimals="0"
      id="Fact000107"
      unitRef="USD">-0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2025-01-012025-12-31_ecd_PeoMember_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_custom_MrJaramilloMember"
      decimals="0"
      id="Fact000108"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2025-01-012025-12-31_ecd_PeoMember_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_custom_MrJaramilloMember"
      decimals="0"
      id="Fact000109"
      unitRef="USD">-0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2025-01-012025-12-31_ecd_PeoMember_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_custom_MrJaramilloMember"
      decimals="0"
      id="Fact000110"
      unitRef="USD">-0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2025-01-012025-12-31_ecd_PeoMember_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_custom_MrJaramilloMember"
      decimals="0"
      id="Fact000111"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2025-01-012025-12-31_ecd_PeoMember_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember_custom_MrJaramilloMember"
      decimals="0"
      id="Fact000112"
      unitRef="USD">-0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2024-01-012024-12-31_ecd_PeoMember_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_custom_MrJaramilloMember"
      decimals="0"
      id="Fact000113"
      unitRef="USD">-0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2024-01-012024-12-31_ecd_PeoMember_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_custom_MrJaramilloMember"
      decimals="0"
      id="Fact000114"
      unitRef="USD">-9977</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2024-01-012024-12-31_ecd_PeoMember_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_custom_MrJaramilloMember"
      decimals="0"
      id="Fact000115"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2024-01-012024-12-31_ecd_PeoMember_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_custom_MrJaramilloMember"
      decimals="0"
      id="Fact000116"
      unitRef="USD">-1254</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2024-01-012024-12-31_ecd_PeoMember_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_custom_MrJaramilloMember"
      decimals="0"
      id="Fact000117"
      unitRef="USD">-10316</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2024-01-012024-12-31_ecd_PeoMember_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_custom_MrJaramilloMember"
      decimals="0"
      id="Fact000118"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2024-01-012024-12-31_ecd_PeoMember_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember_custom_MrJaramilloMember"
      decimals="0"
      id="Fact000119"
      unitRef="USD">-21547</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_ecd_PeoMember_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_custom_MrJaramilloMember"
      decimals="0"
      id="Fact000120"
      unitRef="USD">9813</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_ecd_PeoMember_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_custom_MrJaramilloMember"
      decimals="0"
      id="Fact000121"
      unitRef="USD">-9665</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_ecd_PeoMember_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_custom_MrJaramilloMember"
      decimals="0"
      id="Fact000122"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_ecd_PeoMember_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_custom_MrJaramilloMember"
      decimals="0"
      id="Fact000123"
      unitRef="USD">-4270</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_ecd_PeoMember_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_custom_MrJaramilloMember"
      decimals="0"
      id="Fact000124"
      unitRef="USD">-9931</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_ecd_PeoMember_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_custom_MrJaramilloMember"
      decimals="0"
      id="Fact000125"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_ecd_PeoMember_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember_custom_MrJaramilloMember"
      decimals="0"
      id="Fact000126"
      unitRef="USD">-14053</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2025-01-012025-12-31_ecd_PeoMember_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_custom_MrErbMember"
      decimals="0"
      id="Fact000127"
      unitRef="USD">2040</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2025-01-012025-12-31_ecd_PeoMember_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_custom_MrErbMember"
      decimals="0"
      id="Fact000128"
      unitRef="USD">-0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2025-01-012025-12-31_ecd_PeoMember_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_custom_MrErbMember"
      decimals="0"
      id="Fact000129"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2025-01-012025-12-31_ecd_PeoMember_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_custom_MrErbMember"
      decimals="0"
      id="Fact000130"
      unitRef="USD">-0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2025-01-012025-12-31_ecd_PeoMember_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_custom_MrErbMember"
      decimals="0"
      id="Fact000131"
      unitRef="USD">-0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2025-01-012025-12-31_ecd_PeoMember_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_custom_MrErbMember"
      decimals="0"
      id="Fact000132"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2025-01-012025-12-31_ecd_PeoMember_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember_custom_MrErbMember"
      decimals="0"
      id="Fact000133"
      unitRef="USD">2040</ecd:AdjToCompAmt>
    <ecd:AdjToNonPeoNeoCompFnTextBlock contextRef="From2025-01-01to2025-12-31" id="Fact000135">&lt;p id="xdx_844_eecd--AdjToNonPeoNeoCompFnTextBlock_dU_zIjdQLQEJAEc" style="margin-top: 0; margin-bottom: 0"&gt;&#160;&lt;/p&gt;
&lt;table cellpadding="0" cellspacing="0" id="xdx_305_zZMNMFwQQ82f" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Pay vs Performance Disclosure"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"&gt;&lt;b&gt;Year&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;Average Reported
    Summary Compensation Table Total for Non-PEO NEOs ($)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;Less&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;Average Reported
    Value of Equity Awards ($)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;Plus&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"&gt;&lt;b&gt;Average
                                         Equity Award Adjustments &lt;br/&gt;
($)&lt;sup&gt;(a)&lt;/sup&gt;&lt;/b&gt;&lt;/span&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 9pt"&gt;Equals&lt;/span&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 9pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;&lt;p style="border-bottom: black 1pt solid; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 9pt"&gt;&lt;b&gt;Average
                                         CAP for Non-PEO NEOs &lt;br/&gt;
($)&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 12%; text-align: left"&gt;2025&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_985_eecd--NonPeoNeoAvgTotalCompAmt_dxL_c20250101__20251231_zc7DlOcNnAM2" style="width: 12%; text-align: right" title="::XDX::306100"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0136"&gt;306,099&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 12%; font-weight: bold; text-align: center"&gt;-&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_989_eecd--AdjToCompAmt_d0_c20250101__20251231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--EqtyAwrdsInSummryCompstnTblForAplblYrMember_zxEZLTEGJYGi" style="width: 12%; font-weight: bold; text-align: center"&gt;-&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 12%; text-align: center"&gt;+&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_983_eecd--AdjToCompAmt_d0_c20250101__20251231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember_fKGEp_zplNSDXOaIAl" style="width: 11%; font-weight: bold; text-align: center"&gt;-&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td style="width: 11%; text-align: center"&gt;=&lt;/td&gt;&lt;td style="width: 1%"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_981_eecd--NonPeoNeoAvgCompActuallyPaidAmt_dxL_c20250101__20251231_zHzEdYJplPPh" style="width: 11%; text-align: center" title="::XDX::306100"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0139"&gt;306,099&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;2024&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_982_eecd--NonPeoNeoAvgTotalCompAmt_c20240101__20241231_z3hnFYVZowM2" style="text-align: right"&gt;288,472&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;-&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_985_eecd--AdjToCompAmt_d0_c20240101__20241231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--EqtyAwrdsInSummryCompstnTblForAplblYrMember_zpJRwiKH2I6a" style="font-weight: bold; text-align: center"&gt;-&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;+&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98D_eecd--AdjToCompAmt_c20240101__20241231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember_fKGEp_zzAwxvlhKjoe" style="text-align: center"&gt;(16,542)&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;=&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98A_eecd--NonPeoNeoAvgCompActuallyPaidAmt_c20240101__20241231_zLhjeoA7SKsc" style="text-align: center"&gt;271,930&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;2023&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_98F_eecd--NonPeoNeoAvgTotalCompAmt_dxL_c20230101__20231231_ztSc5yX6Zsm" style="text-align: right" title="::XDX::446458"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0144"&gt;297,639&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&#160;&lt;/td&gt;
    &lt;td style="font-weight: bold; text-align: center"&gt;-&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_981_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--EqtyAwrdsInSummryCompstnTblForAplblYrMember_z7DjYdx9w0wi" style="text-align: center"&gt;97,176&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;+&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_986_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember_fKGEp_zCAHZ30OFov1" style="text-align: center"&gt;1,903&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td style="text-align: center"&gt;=&lt;/td&gt;&lt;td&gt;&#160;&lt;/td&gt;
    &lt;td id="xdx_989_eecd--NonPeoNeoAvgCompActuallyPaidAmt_dxL_c20230101__20231231_zrmLs5YXjQEl" style="text-align: center" title="::XDX::351185"&gt;&lt;span style="-sec-ix-hidden: xdx2ixbrl0147"&gt;202,366&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;p style="margin: 0"&gt;&#160;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"&gt;&lt;tr style="vertical-align: top; text-align: justify"&gt;
&lt;td style="width: 4%; text-align: left"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"&gt;&lt;sup id="xdx_F01_zlAQ0Yl1zqD3"&gt;(a)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;&lt;td style="text-align: left; width: 96%"&gt;&lt;span id="xdx_F1C_zbgrviJYUvSk" style="font-family: Times New Roman, Times, Serif; font-size: 8pt"&gt;See
                                         note (b) to footnote (2) above for an explanation of the equity award adjustments made
                                         in accordance with Item 402(v) of Regulation S-K. The amounts deducted or added in calculating
                                         the total average equity award adjustments for the other NEOs as a group (excluding Mr.
                                         Erb and Mr. Jaramillo) are as follows:&lt;/span&gt;&lt;/td&gt;
&lt;/tr&gt;&lt;/table&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; margin-left: 0in; text-indent: 0.5in; text-align: justify"&gt;&lt;span style="font: 10pt Times New Roman, Times, Serif"&gt;&#160;&lt;/span&gt;&lt;/p&gt;
&lt;table cellpadding="0" cellspacing="0" id="xdx_30F_zaPOFVMRpDT7" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%" summary="xdx: Disclosure - Pay vs Performance Disclosure"&gt;
&lt;tr style="vertical-align: bottom"&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: left"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"&gt;&lt;b&gt;Year&lt;/b&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="padding-bottom: 1pt"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; text-align: center"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"&gt;&lt;b&gt;Average
                                         Year End Fair Value of Equity Awards Granted in the Year and Outstanding and Unvested
                                         at Year End&lt;/b&gt;&lt;/span&gt;&lt;span style="font-size: 8pt"&gt;&lt;br/&gt; &lt;span style="font-family: Times New Roman, Times, Serif"&gt;&lt;b&gt;($)&lt;/b&gt;&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;Year over Year
    Average Change in Fair Value of Outstanding and Unvested Equity Awards&lt;br/&gt; ($)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;Average Fair
    Value as of Vesting Date of Equity Awards Granted and Vested in the Year&lt;br/&gt; ($)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;Average Change
    in Fair Value to the Vesting Date of Equity Awards Granted in Prior Years that Vested in the Year&lt;br/&gt; ($)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;Average Fair
    Value at the End of the Prior Year of Equity Awards that Failed to Meet Vesting Conditions in the Year&lt;br/&gt; ($)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;Average Value
    of Dividends or Other Earnings Paid on Stock or Option Awards not Otherwise Reflected in Fair Value or Total Compensation&lt;br/&gt;
    ($)&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold; padding-bottom: 1pt"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;Total Average
    Equity Award Adjustments&lt;br/&gt; ($)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="width: 12%; text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eecd--AdjToCompAmt_d0_c20250101__20251231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_zHoVgd3rFLF3" style="width: 12%; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eecd--AdjToCompAmt_d0_c20250101__20251231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_zSBVx4AOl4uh" style="width: 12%; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98E_eecd--AdjToCompAmt_c20250101__20251231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_zSPePhvKBaGl" style="width: 12%; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eecd--AdjToCompAmt_d0_c20250101__20251231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_zMk6Fznvez91" style="width: 12%; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eecd--AdjToCompAmt_d0_c20250101__20251231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_zmo31xGAunWl" style="width: 11%; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eecd--AdjToCompAmt_c20250101__20251231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_zMdarFrO85z3" style="width: 11%; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td style="width: 1%; font-weight: bold"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eecd--AdjToCompAmt_d0_c20250101__20251231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember_zyJB2gxIUkfj" style="width: 11%; font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: White"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td style="font-weight: bold"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eecd--AdjToCompAmt_d0_c20240101__20241231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_zO8z9WJLEZGd" style="font-weight: bold; text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;-&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_983_eecd--AdjToCompAmt_c20240101__20241231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_zLsJYh5M1Hdd" style="text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;(6,517)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eecd--AdjToCompAmt_c20240101__20241231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_zFigXYiszBIl" style="text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eecd--AdjToCompAmt_c20240101__20241231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_zoXaREJuz8wk" style="text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;(3,255)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eecd--AdjToCompAmt_c20240101__20241231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_zsQNsixgLkxg" style="text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;(6,770)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eecd--AdjToCompAmt_c20240101__20241231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_zV7Wc9BGfRWd" style="text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98C_eecd--AdjToCompAmt_c20240101__20241231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember_zbBNUlR1fCvi" style="text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;(16,542)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="vertical-align: bottom; background-color: rgb(204,238,255)"&gt;
    &lt;td style="text-align: left"&gt;&lt;span style="font-size: 8pt"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember_zudq02CBEk7b" style="text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;6,481&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98F_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember_zZLXDZlp6Fih" style="text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;(1,452)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_984_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember_zmw8Xn24C2Sk" style="text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_982_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember_zJCaOuTdJfEb" style="text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;(1,633)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_987_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember_zq79ZUR0ZIPh" style="text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;(1,493)&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_988_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember_zpYVQMR5h9l8" style="text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;0&lt;/span&gt;&lt;/td&gt;&lt;td&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td id="xdx_98D_eecd--AdjToCompAmt_c20230101__20231231__ecd--ExecutiveCategoryAxis__ecd--NonPeoNeoMember__ecd--AdjToCompAxis__ecd--EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember_zjq2sjiMJsUa" style="text-align: center"&gt;&lt;span style="font-size: 8pt"&gt;1,903&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

&lt;p style="margin-top: 0; margin-bottom: 0"&gt;&lt;span style="font-size: 8pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 4%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"&gt;&lt;sup&gt;(5)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 96%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"&gt;The
    amounts reported in this column represent the Company&#x2019;s cumulative TSR, which is calculated by dividing the sum of the
    cumulative amount of dividends for the measurement period, assuming dividend reinvestment, and the difference between the
    Company&#x2019;s share price at the end of the measurement period and the beginning of the measurement period by the Company&#x2019;s
    share price at the beginning of the measurement period.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 4%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"&gt;&lt;sup&gt;(6)&lt;/sup&gt;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 96%"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"&gt;The
    amounts reported in this column represent net income reflected in the Company&#x2019;s audited financial statements for the
    applicable year.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;

</ecd:AdjToNonPeoNeoCompFnTextBlock>
    <ecd:AdjToCompAmt
      contextRef="From2025-01-012025-12-31_ecd_NonPeoNeoMember_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember"
      decimals="0"
      id="Fact000137"
      unitRef="USD">-0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2025-01-012025-12-31_ecd_NonPeoNeoMember_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember"
      decimals="0"
      id="Fact000138"
      unitRef="USD">-0</ecd:AdjToCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt
      contextRef="From2024-01-012024-12-31"
      decimals="0"
      id="Fact000140"
      unitRef="USD">288472</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2024-01-012024-12-31_ecd_NonPeoNeoMember_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember"
      decimals="0"
      id="Fact000141"
      unitRef="USD">-0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2024-01-012024-12-31_ecd_NonPeoNeoMember_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember"
      decimals="0"
      id="Fact000142"
      unitRef="USD">-16542</ecd:AdjToCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt
      contextRef="From2024-01-012024-12-31"
      decimals="0"
      id="Fact000143"
      unitRef="USD">271930</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_ecd_NonPeoNeoMember_ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember"
      decimals="0"
      id="Fact000145"
      unitRef="USD">97176</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_ecd_NonPeoNeoMember_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember"
      decimals="0"
      id="Fact000146"
      unitRef="USD">1903</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2025-01-012025-12-31_ecd_NonPeoNeoMember_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember"
      decimals="0"
      id="Fact000149"
      unitRef="USD">-0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2025-01-012025-12-31_ecd_NonPeoNeoMember_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember"
      decimals="0"
      id="Fact000150"
      unitRef="USD">-0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2025-01-012025-12-31_ecd_NonPeoNeoMember_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember"
      decimals="0"
      id="Fact000151"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2025-01-012025-12-31_ecd_NonPeoNeoMember_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember"
      decimals="0"
      id="Fact000152"
      unitRef="USD">-0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2025-01-012025-12-31_ecd_NonPeoNeoMember_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember"
      decimals="0"
      id="Fact000153"
      unitRef="USD">-0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2025-01-012025-12-31_ecd_NonPeoNeoMember_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember"
      decimals="0"
      id="Fact000154"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2025-01-012025-12-31_ecd_NonPeoNeoMember_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember"
      decimals="0"
      id="Fact000155"
      unitRef="USD">-0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2024-01-012024-12-31_ecd_NonPeoNeoMember_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember"
      decimals="0"
      id="Fact000156"
      unitRef="USD">-0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2024-01-012024-12-31_ecd_NonPeoNeoMember_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember"
      decimals="0"
      id="Fact000157"
      unitRef="USD">-6517</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2024-01-012024-12-31_ecd_NonPeoNeoMember_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember"
      decimals="0"
      id="Fact000158"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2024-01-012024-12-31_ecd_NonPeoNeoMember_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember"
      decimals="0"
      id="Fact000159"
      unitRef="USD">-3255</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2024-01-012024-12-31_ecd_NonPeoNeoMember_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember"
      decimals="0"
      id="Fact000160"
      unitRef="USD">-6770</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2024-01-012024-12-31_ecd_NonPeoNeoMember_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember"
      decimals="0"
      id="Fact000161"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2024-01-012024-12-31_ecd_NonPeoNeoMember_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember"
      decimals="0"
      id="Fact000162"
      unitRef="USD">-16542</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_ecd_NonPeoNeoMember_ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember"
      decimals="0"
      id="Fact000163"
      unitRef="USD">6481</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_ecd_NonPeoNeoMember_ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember"
      decimals="0"
      id="Fact000164"
      unitRef="USD">-1452</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_ecd_NonPeoNeoMember_ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember"
      decimals="0"
      id="Fact000165"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_ecd_NonPeoNeoMember_ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember"
      decimals="0"
      id="Fact000166"
      unitRef="USD">-1633</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_ecd_NonPeoNeoMember_ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember"
      decimals="0"
      id="Fact000167"
      unitRef="USD">-1493</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_ecd_NonPeoNeoMember_ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember"
      decimals="0"
      id="Fact000168"
      unitRef="USD">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt
      contextRef="From2023-01-012023-12-31_ecd_NonPeoNeoMember_ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember"
      decimals="0"
      id="Fact000169"
      unitRef="USD">1903</ecd:AdjToCompAmt>
    <ecd:Additional402vDisclosureTextBlock contextRef="From2025-01-01to2025-12-31" id="Fact000171">&lt;p id="xdx_840_eecd--Additional402vDisclosureTextBlock_dU_z45viW6u8hkc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
Company is providing the following descriptions of the relationships between information presented in the Pay Versus Performance
table, including Compensation Actually Paid (CAP), as required by Item 402(v) of Regulation S-K. The Compensation Committee does
not use TSR or net income in its compensation programs. However, we do utilize several other performance measures to align executive
compensation with our performance, see &#x201c;Named Executive Officer Compensation.&#x201d; Part of the compensation our non-PEO
NEOs are eligible to receive consists of annual discretionary bonuses equal to 25% of the total bonus opportunity per non-PEO
NEO that are designed to provide appropriate incentives to our executives to achieve defined annual corporate goals and to reward
our executives for individual achievement toward these goals, subject to certain criteria. The PEO&#x2019;s bonus opportunity for
each of 2025 and 2024 was based solely on the achievement of corporate objectives.&lt;/span&gt;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/p&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; padding-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For 2025, the compensation
    actually paid for the PEO and the non-PEO NEOs as a percentage of net loss was approximately 3.6% and 1.7%, respectively.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For 2024, the compensation
    actually paid for the PEO and the non-PEO NEOs as a percentage of net loss was approximately 3.5% and 2.4%, respectively.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;


&lt;div style="border-bottom: Black 1pt solid; margin-top: 6pt; margin-bottom: 6pt"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; text-align: center; margin-bottom: 0pt"&gt;26&#160;&lt;/p&gt;&lt;/div&gt;
    &lt;div style="page-break-before: always; margin-top: 6pt"&gt;&lt;p style="margin: 0pt"&gt;&#160;&lt;/p&gt;&lt;/div&gt;
    &lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; padding-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;For 2023, the compensation
    actually paid for the PEO and the non-PEO NEOs as a percentage of net loss was approximately 2.1% and 1.7%, respectively.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; padding-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Compensation actually
    paid to the PEO increased by $249,787, or approximately 64.4%, in 2025.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Average compensation
    actually paid to the remaining non-PEO NEOs increased by $34,170, or approximately 12.6%, in 2025.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;

&lt;table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0; width: 0.5in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0; width: 0.25in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;TSR decreased from
    $5.46 in 2024 to $3.73 in 2025, or approximately 31.7%.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;TSR increased from
    $5.42 in 2023 to $5.46 in 2024, or approximately 0.8%.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Net Loss increased
    approximately 56.7% from 2024 to 2025.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Net Loss decreased
    approximately 44.8% from 2023 to 2024.&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Net Sales Growth
    was (1.4)% in 2024 and (5.4)% in 2025&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#160;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;&#x25cf;&lt;/span&gt;&lt;/td&gt;
    &lt;td style="font: 10pt Times New Roman, Times, Serif; padding-left: 0"&gt;&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0in"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;Net
Sales Growth was 3.8% in 2023 and (1.4)% in 2024.&lt;/span&gt;&#160;&lt;/p&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;
&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&#160;&lt;/p&gt;

&lt;p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"&gt;&lt;span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"&gt;The
changes in compensation actually paid to our PEO during such periods as described in the pay versus performance table were largely
driven by the fact that we had two PEOs in 2025, one of whom (Mr. Jaramillo) received separation pay in the amount of $224,561 that is included in the calculations of total compensation and compensation actually paid for Mr. Jaramillo in such period. The
changes in average compensation actually paid to our non-PEO NEOs reflect the fact that Mr. Ayotte received a one-time bonus in
the amount of $10,000 for his temporary service leading the Company&#x2019;s Human Resources and Regulatory functions during 2025.&lt;/span&gt;&lt;/p&gt;

</ecd:Additional402vDisclosureTextBlock>
    <link:footnoteLink
      xlink:role="http://www.xbrl.org/2003/role/link"
      xlink:type="extended">
        <link:loc
          xlink:href="#Fact000027"
          xlink:label="Fact000027"
          xlink:type="locator"/>
        <link:footnote id="Footnote000076" xlink:label="Footnote000076" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Reflects
    the amount reported in the &#x201c;Total&#x201d; column of the Summary Compensation Table for each of <xhtml:span id="xdx_90B_eecd--PeoName_c20250101__20251231__ecd--IndividualAxis__custom--MrErbMember_zf1sFgyp6Dua">Mr. Erb</xhtml:span> and <xhtml:span id="xdx_904_eecd--PeoName_c20230101__20231231__ecd--IndividualAxis__custom--MrJaramilloMember_zPUdSol0ZkZ5"><xhtml:span id="xdx_901_eecd--PeoName_c20240101__20241231__ecd--IndividualAxis__custom--MrJaramilloMember_zUxUINMYfZj3"><xhtml:span id="xdx_904_eecd--PeoName_c20250101__20250228__ecd--IndividualAxis__custom--MrJaramilloMember_zpuUh1Zryfi3">Mr. Jaramillo</xhtml:span></xhtml:span></xhtml:span>
    for each corresponding year in which they served as PEO. Mr. Jaramillo was our PEO from 2023 to February 2025, and Mr. Erb
    was our PEO from February 2025 to December 2025. The amount reported in the &#x201c;Total&#x201d; column of the Summary Compensation
    Table for Mr. Jaramillo includes $224,561.19 of Separation Pay in 2025. The amount reported in the &#x201c;Total&#x201d; column
    of the Summary Compensation Table for Mr. Erb includes $49,300 and $8,036 of compensation for service as Chairman of the Board
    in 2024 and 2025, respectively. See &#x201c;Named Executive Officer Compensation Tables - Summary Compensation Table for 2025
    and 2024&#x201d; and &#x201c;Named Executive Officer Compensation Tables - Summary Compensation Table for 2024 and 2023&#x201d;
    in our 2025 Definitive Proxy Statement filed with the SEC on April 14, 2025.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000027"
          xlink:to="Footnote000076"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000031"
          xlink:label="Fact000031"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000031"
          xlink:to="Footnote000076"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000035"
          xlink:label="Fact000035"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000035"
          xlink:to="Footnote000076"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000039"
          xlink:label="Fact000039"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000039"
          xlink:to="Footnote000076"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000043"
          xlink:label="Fact000043"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000043"
          xlink:to="Footnote000076"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000047"
          xlink:label="Fact000047"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000047"
          xlink:to="Footnote000076"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000029"
          xlink:label="Fact000029"
          xlink:type="locator"/>
        <link:footnote id="Footnote000081" xlink:label="Footnote000081" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The amounts reported in this column represent CAP for Mr. Erb and Mr. Jaramillo for each corresponding year in which they served as PEO
computed as required by Item 402(v) of Regulation S-K. The reported amounts do not reflect the actual compensation earned by or paid to
Mr. Erb or Mr. Jaramillo during any applicable year. To determine CAP, the adjustments below were made to Mr. Erb&#x2019;s and Mr. Jaramillo&#x2019;s
total compensation.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000029"
          xlink:to="Footnote000081"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000033"
          xlink:label="Fact000033"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000033"
          xlink:to="Footnote000081"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000037"
          xlink:label="Fact000037"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000037"
          xlink:to="Footnote000081"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000041"
          xlink:label="Fact000041"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000041"
          xlink:to="Footnote000081"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000045"
          xlink:label="Fact000045"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000045"
          xlink:to="Footnote000081"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000049"
          xlink:label="Fact000049"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000049"
          xlink:to="Footnote000081"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000051"
          xlink:label="Fact000051"
          xlink:type="locator"/>
        <link:footnote id="Footnote000082" xlink:label="Footnote000082" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Reflects the average amount reported in the &#x201c;Total&#x201d; column of the Summary Compensation Table for our other NEOs as a group
(excluding Mr. Erb and Mr. Jaramillo) for each corresponding year. See &#x201c;Named Executive Officer Compensation Tables - Summary Compensation
Table for 2025 and 2024&#x201d; and &#x201c;Named Executive Officer Compensation Tables - Summary Compensation Table for 2024 and 2023&#x201d;
in our 2025 Definitive Proxy Statement filed with the SEC on April 14, 2025. The names of each of the other NEOs (excluding Mr. Erb and
Mr. Jaramillo) Included for purposes of calculating the average amounts in each applicable year are Mr. Ayotte, Ms. Blake, and Mr. Scott
for 2023, Mr. Ayotte and Mr. Scott for 2024, and Mr. Ayotte and Mr. Scott for 2025. Since Ms. Blake and Mr. Scott served as Chief Financial
Officer for a portion of 2023 and Mr. Scott served as Chief Financial Officer for a portion of 2025, the compensation of each such non-PEO
NEO has been included for purposes of calculating the average summary compensation table total in each respective year. In addition to
serving as our PEO, Mr. Erb served as Interim Chief Financial Officer for a portion of 2025 and did not receive any additional compensation
for serving in this role during the applicable year. Mr. Erb&#x2019;s compensation for 2025 has not been included for purposes of calculating
the average summary compensation total in that year.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000051"
          xlink:to="Footnote000082"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000059"
          xlink:label="Fact000059"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000059"
          xlink:to="Footnote000082"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000067"
          xlink:label="Fact000067"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000067"
          xlink:to="Footnote000082"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000053"
          xlink:label="Fact000053"
          xlink:type="locator"/>
        <link:footnote id="Footnote000083" xlink:label="Footnote000083" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Amounts reported reflect CAP for the other NEOs as a group (excluding Mr. Erb and Mr. Jaramillo), as computed in accordance with Item
402(v) of Regulation S- K, for each corresponding year, which amounts reflect an average of the actual amount of compensation earned by
or paid to the other NEOs as a group (excluding Mr. Erb and Mr. Jaramillo) during the applicable year. The adjustments below were made
to the average total compensation for the NEOs as a group (excluding Mr. Erb and Mr. Jaramillo) for each year to determine the CAP for
such year. Since both Ms. Blake and Mr. Scott served as Chief Financial Officer for a portion of 2023, and Mr. Scott served as Chief Financial
Officer for a portion of 2025, these two non-PEO NEOs have been treated as one full-time equivalent individual for purposes of calculating
the average compensation actually paid to non-PEO NEOs in each respective year. In addition to serving as our PEO, Mr. Erb served as Interim
Chief Financial Officer for a portion of 2025 and did not receive any additional compensation for serving in this role during the applicable
year.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000053"
          xlink:to="Footnote000083"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000061"
          xlink:label="Fact000061"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000061"
          xlink:to="Footnote000083"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000069"
          xlink:label="Fact000069"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000069"
          xlink:to="Footnote000083"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000055"
          xlink:label="Fact000055"
          xlink:type="locator"/>
        <link:footnote id="Footnote000084" xlink:label="Footnote000084" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The amounts reported in this column represent the Company&#x2019;s cumulative TSR, which is calculated by dividing the sum of the cumulative
amount of dividends for the measurement period, assuming dividend reinvestment, and the difference between the Company&#x2019;s share price
at the end of the measurement period and the beginning of the measurement period by the Company&#x2019;s share price at the beginning of
the measurement period.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000055"
          xlink:to="Footnote000084"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000063"
          xlink:label="Fact000063"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000063"
          xlink:to="Footnote000084"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000071"
          xlink:label="Fact000071"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000071"
          xlink:to="Footnote000084"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000057"
          xlink:label="Fact000057"
          xlink:type="locator"/>
        <link:footnote id="Footnote000085" xlink:label="Footnote000085" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The amounts reported in this column represent net income reflected in the Company&#x2019;s audited financial statements for the applicable
year.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000057"
          xlink:to="Footnote000085"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000065"
          xlink:label="Fact000065"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000065"
          xlink:to="Footnote000085"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000073"
          xlink:label="Fact000073"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000073"
          xlink:to="Footnote000085"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000089"
          xlink:label="Fact000089"
          xlink:type="locator"/>
        <link:footnote id="Footnote000104" xlink:label="Footnote000104" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">Amounts
    reflect the grant date fair value of equity awards as reported in the &#x201c;Option Awards&#x201d; column in the Summary Compensation
    Table for the applicable year.</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000089"
          xlink:to="Footnote000104"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000093"
          xlink:label="Fact000093"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000093"
          xlink:to="Footnote000104"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000097"
          xlink:label="Fact000097"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000097"
          xlink:to="Footnote000104"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000101"
          xlink:label="Fact000101"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000101"
          xlink:to="Footnote000104"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000090"
          xlink:label="Fact000090"
          xlink:type="locator"/>
        <link:footnote id="Footnote000105" xlink:label="Footnote000105" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">The
                                         equity award adjustments were calculated in accordance with Item 402(v) of Regulation
                                         S-K and include: (i) the year-end fair value of any equity awards granted in the applicable
                                         year that are outstanding and unvested as of the end of the year; (ii) the amount of
                                         change as of the end of the applicable year (from the end of the prior fiscal year) in
                                         fair value of any awards granted in prior years that are outstanding and unvested as
                                         of the end of the applicable year; (iii) for awards that are granted in the applicable
                                         year and vest in the same year, the fair value as of the vesting date;(iv) for awards
                                         granted in prior years that vest in the applicable year, the amount equal to the change
                                         as of the vesting date (from the end of the prior fiscal year) in fair value; (v) for
                                         awards granted in prior years that are determined to fail to meet the applicable vesting
                                         conditions during the applicable year, a deduction for the amount equal to the fair value
                                         at the end of the prior fiscal year; and (vi) the dollar value of any dividends or other
                                         earnings paid on stock or option awards in the applicable year prior to the vesting date
                                         that are not otherwise reflected in the fair value of such award or included in any other
                                         component of total compensation for the applicable year. The valuation assumptions used
                                         to calculate fair values did not materially differ from those disclosed at the time of
                                         grant. The amounts deducted or added in calculating the equity award adjustments for
                                         each of Mr. Erb and Mr. Jaramillo for the years in which they served as PEO are as follows:</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000090"
          xlink:to="Footnote000105"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000094"
          xlink:label="Fact000094"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000094"
          xlink:to="Footnote000105"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000098"
          xlink:label="Fact000098"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000098"
          xlink:to="Footnote000105"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000102"
          xlink:label="Fact000102"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000102"
          xlink:to="Footnote000105"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000138"
          xlink:label="Fact000138"
          xlink:type="locator"/>
        <link:footnote id="Footnote000148" xlink:label="Footnote000148" xlink:role="http://www.xbrl.org/2003/role/footnote" xlink:type="resource" xml:lang="en-US">See
                                         note (b) to footnote (2) above for an explanation of the equity award adjustments made
                                         in accordance with Item 402(v) of Regulation S-K. The amounts deducted or added in calculating
                                         the total average equity award adjustments for the other NEOs as a group (excluding Mr.
                                         Erb and Mr. Jaramillo) are as follows:</link:footnote>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000138"
          xlink:to="Footnote000148"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000142"
          xlink:label="Fact000142"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000142"
          xlink:to="Footnote000148"
          xlink:type="arc"/>
        <link:loc
          xlink:href="#Fact000146"
          xlink:label="Fact000146"
          xlink:type="locator"/>
        <link:footnoteArc
          xlink:arcrole="http://www.xbrl.org/2003/arcrole/fact-footnote"
          xlink:from="Fact000146"
          xlink:to="Footnote000148"
          xlink:type="arc"/>
    </link:footnoteLink>
</xbrl>
